The Smallpox Vaccination Campaign of 2003: Why Did It Failand What Are the Lessons for Bioterrorism Preparedness? by Richards, Edward P. et al.
Louisiana Law Review
Volume 64 | Number 4
Normalization of National Security Law: A
Symposium
Summer 2004
The Smallpox Vaccination Campaign of 2003:
Why Did It Failand What Are the Lessons for
Bioterrorism Preparedness?
Edward P. Richards
Louisiana State University Law Center
Katharine C. Rathbun
Jay Gold
This Article is brought to you for free and open access by the Law Reviews and Journals at LSU Law Digital Commons. It has been accepted for
inclusion in Louisiana Law Review by an authorized editor of LSU Law Digital Commons. For more information, please contact kreed25@lsu.edu.
Repository Citation
Edward P. Richards, Katharine C. Rathbun, and Jay Gold, The Smallpox Vaccination Campaign of 2003: Why Did It Failand What Are
the Lessons for Bioterrorism Preparedness?, 64 La. L. Rev. (2004)
Available at: https://digitalcommons.law.lsu.edu/lalrev/vol64/iss4/6
The Smallpox Vaccination Campaign of 2003: Why
Did It Failand What Are the Lessons for
Bioterrorism Preparedness?'
Edward P. Richards*
Katharine C. Rathbun**
Jay Gold***
I. INTRODUCTION
On December 13, 2002, the White House announced a plan to
vaccinate active duty military personnel and certain civilian
hospital, health care, and emergency services workers against
smallpox.2 This announcement was accompanied by a Smallpox
Vaccination FAQ.3 The goal was to vaccinate 500,000 military
personnel as soon as possible, and then to vaccinate 500,000
civilians within a few weeks. There were no specific plans to
vaccinate the general population, but there was discussion about
making the smallpox vaccine available to the general public in
2004. President Bush was immunized first, with no reported ill
effects.4
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1. Available with hyperlinks at http://biotech.law.lsu.edu/blaw/bt/
smallpox/svlaw.htm.
2. Press Release, Protecting Americans: Smallpox Vaccination Program,
(December 13, 2002), available at http://www.whitehouse.gov/news/
releases/2002/12/20021213-1.html (last accessed Aug. 14, 2004) and
http://biotech.law.lsu.edu/blaw/bt/smallpox/vaccination-program-statement.pdf (a
"Fact Sheet' issued with President Bush's statement announcing the new program).
Only the Presidential Statement itself has been retained by the National Archives
and Records Administration. Remarks Announcing the Smallpox Vaccination Plan,
38 Weekly Comp. of Pres. Doc. 2162 (Dec. 16, 2002), available at
http://www.gpoaccess.gov/wcomp/v38no50.html. The supporting papers issued
with the statement do not appear in the Weekly Compilation of Presidential
Documents. See id.
3. Press Release, Frequently Asked Questions, Smallpox Response Teams
(Dec. 13, 2002), available at http://www.whitehouse.gov/
news/releases/20O2/12/20021213-3.html and http://biotech.law.lsu.edu/blaw/bt/
smallpox/whfaq.htm.
4. See Mike Allen, Bush Receives Smallpox Vaccine, Wash. Post, Dec. 22,
2002, at A11; Bush Fine After Vaccine, Wash. Post, Dec. 23, 2002, at A5.
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By January 2004, 578,286 military personnel were vaccinated.5
During the same period, only 39,213 civilian health-care and public
health workers were vaccinated, less than ten percent of the original
goal.6 This article analyzes why the civilian smallpox vaccination
campaign failed, the impact of this failure, and what it should teach
us about future vaccination campaigns for smallpox and other
bioterrorism agents. Some of the reasons for failure could have been
averted with better planning and legislation, but others are intrinsic
to the United States's medical and legal systems. Addressing these
intrinsic problems demands fundamental modifications in the plans
for bioterrorism preparedness.
This article does not discuss the control of a smallpox outbreak,
beyond the use of smallpox vaccinations. Control measures would
include stopping all transportation in and out of the affected area,
identifying all cases, persons in contact with those cases or in contact
with contacts of those cases, vaccinating and isolating the contacts,
and trying to preserve social order and infrastructure in the affected
region. Such measures would require military intervention as
discussed in other papers in this symposium issue. It is possible that
we would see the breakdown of civil order and imposition of martial
law. The authors believe that such measures will be nearly
impossible to carry out because they pose difficult moral and ethical
dilemmas such as whether to shoot the soccer mom with the minivan
full of kids trying to get out of the city. As a result, the authors stress
the importance of a workable vaccination program which can stop the
epidemic even if draconian control measures fail.
This article originated in the Smallpox Vaccine Injury and Legal
Guide,7 an online analysis of the medical and legal issues posed by
5. Centers for Disease Control and Prevention, Secondary and Tertiary
Transfer of Vaccinia Virus Among U.S. Military Personnel-United States and
Worldwide, 2002-2004, 53 MMWR 103 (2004), available at http://www.cdc.gov/
mmwr/PDF/wk/mm5305.pdf and http://biotech.law.lsu.edu/cdc/
mm5305.pdf#page=7.
6. Centers for Disease Control and Prevention, Update: Adverse Events
Following Civilian Smallpox Vaccination-United States, 2003, 53 MMWR 106
(2004), available at http://www.cdc.gov/mmwr/PDF/wk/mm5305.pdf and
http://biotech.law.lsu.edu/cdc/mm5305.pdf#page=10. This number may include
personnel who were vaccinated through the military reserves, further reducing the
number of civilian volunteers.
7. Edward P. Richards & Katharine C. Rathbun, Smallpox Vaccine Injury and
Law Guide (June 7, 2004), available at http://biotech.law.lsu.edu/blaw/bt/
smallpox/svlaw.htm. For the chronologic develope of the Guide, see the earlier
editions: May 19, 2003, available at http://biotech.law.lsu.edu/blaw/bt/
smallpox/svlawl9may2003.htm; March 26, 2003, available at
http://biotech.law.lsu.edu/blaw/bt/smallpox/svlaw26march03.htm; January 24,
2003, available at http://biotech.law.lsu.edu/blaw/bt/smallpox/svlaw24janO3;
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the smallpox vaccine campaign that was updated as the campaign
progressed. Through the guide and discussions with health care
instutions, unions, health departments, and reporters,8 Professor
Richards and Dr. Rathbun helped many health care organizations
tailor their response to the smallpox vaccine campaign.
II. WHAT WERE THE CORE PROBLEMS WITH THE SMALLPOX
VACCINATION PLAN?
Most of the opposition to the civilian smallpox vaccination plan
came from health care institutions. Their concerns revolved around
six issues that the government failed to address properly when the
plan was announced. While some of these issues have been clarified
since the plan ended, some have yet to be satisfactorily resolved. The
opposition of the health care institutions to the plan effectively
stopped it, leaving open the question of whether the individuals who
were the target of the plan would have cooperated if their institutions
had supported the plan. This article analyzes the following six
queries as they arose during the rollout of the smallpox vaccination
plan, considering the extent to which they have been resolved:
1) What is the real complication rate for smallpox vaccine,
and who is at greatest risk for complications?
2) Is the vaccine being administered in a safe manner?
3) Will worker's compensation cover worker injuries and
lost time?
4) Are all members of the health care team protected by the
legal immunity provisions of the Homeland Security Act?
5) How will persons injured by the vaccine be compensated?
6) Is this plan epidemiologically sound? In other words,
does it improve smallpox preparedness sufficiently to be
worth the risks? If not, is there a better alternative?
While the smallpox vaccination plan was in effect, the authors did not
take a position on whether health care workers should participate.
Such workers were advised to read the CDC's Smallpox Vaccination
in Hospitals-A Hospital Lawyer's Guide (last revised Nov. 30, 2002), available
at http://biotech.law.lsu.edu/blaw/bt/smalpox/hosp-SPold.htm; Edward P.
Richards & Katharine C. Rathbun, Legal Issues Related to Smallpox Immunizations
under the Homeland Security Act (last revised Dec. 14, 2002), available at
http://biotech.law.lsu.edu/blaw/bt/smallpox/304_sp.htm; and Edward P. Richards
& Katharine Rathbun, The Risks of Vaccinating Health Care Workers for
Smallpox-Legal Issues (last revised Dec. 9, 2002), available at
http://biotech.law.lsu.edu/blaw/bt/smallpox/hospSP.htm.
8. Robert Pear, Threats and Responses: Legal Risks; For Victims of Vaccine
Winning Case will be Hard, N.Y. Times, Dec. 14, 2002, at 13.
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and Adverse Reactions: Guidance for Clinicians,9 the
Recommendations of the Advisory Committee on Immunization
Practices (ACIP)-Smallpox, " and the label l for the vaccine, which
contains information that has been left out of the CDC and ACIP
materials. Health care employers were advised to set up surveillance
systems to assure that they are aware of every vaccinated employee
so that they can monitor the employee's vaccine sore and control the
exposure of at-risk patients. They were also advised to identify all
independent contractors in their system who might have contact with
vaccinated persons or who otherwise might be at risk for vaccine-
related injuries. These contractors needed to sign agency agreements
with the employer or the local health department to try to bring them
under the immunity umbrella of the Homeland Security Act. When
most health care employers considered the uncertainties in the plan
along with the medical and legal risks, they decided not to
participate.
Ill. SMALLPOX AS A BIOTERRORISM AGENT
The risk of any smallpox vaccination plans must be evaluated in
the context of the risk of a smallpox outbreak. Smallpox is a highly
contagious viral disease characterized by fever and an eruption of
vesicles and pustules, which kills five to thirty percent of infected
9. Centers for Disease Control and Prevention, Smallpox Vaccination and
Adverse Reactions: Guidance for Clinicians, MMWR Dispatch (Jan. 24, 2003),
available at http://biotech.law.lsu.edu/blaw/bt/smallpox/di52chal/di52chal.htm.
This document was originally published as a Dispatch from the Centers for Disease
Control and Prevention's (CDC) Morbidity and Mortality Weekly Report
(MMWR). However, the CDC no longer maintains the original document. An
updated version was published by the CDC as an MMWR Recommendations and
Reports on February 21, 2003. Centers for Disease Control and Prevention,
Smallpox Vaccination and Adverse Reactions: Guidance for Clinicians, 52
MMWR Recommendations and Reports No. RR-4 (Feb. 21, 2003), available at
http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5204al.htm [Hereinafter CDC,
Guidance II].
10. Centers for Disease Control and Prevention, Recommendations for Using
Smallpox Vaccine in a Pre-Event Vaccination Program-Supplemental
Recommendations of the Advisory Committee on Immunization Practices (ACIP)
and the Healthcare Infection Control Practices Advisory Committee (HICPA C), 52
MMWR Recommendations and Reports No. RR-7 (April 4, 2003), available at
http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5207al.htm and http://www.cdc.
gov/mmwr/PDF/RR/RR5207.pdf [hereinafter CDC, Recommendations].
11. Wyeth Laboratories, Inc., Package Insert Dryvax' (Smallpox Vaccine,
Dried, Calf Lymph Type), available at http://www.fda.gov/
cber/label/smalwye 102502LB.htm, http://www.fda.gov/cber/label/
smalwye102502LB.pdf, and http://biotech.law.lsu.edu/blaw/bt/smallpox/
DRYVAXlabel.htm [hereinafter DryVax® Package Insert].
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persons.12 Infected persons who survive are often terribly disfigured
by the smallpox scars and many are blinded by the disease.' It is
spread through close contact when infected persons cough out
particles of the virus (variola major) from sores in their mouths and
lungs.' 4 These particles can be inhaled, but are more commonly
picked up as tiny dried droplets in the environment and inadvertently
ingested or rubbed into the eyes. 5 The period during which an
infected person can spread the infection is about three weeks, from
just prior to the appearance of the rash until the last scab disappears. 6
About half of those exposed to the virus develop the infection. 7
There is an incubation period of seven to nineteen days (mean:
twelve das) during which the infected person exhibits no
symptoms.
Once infected, a person always goes on to develop symptoms, but
the severity of the cases vary from mild illness to rapid death.'9
Persons who recover from smallpox infection have a long-lasting
immunity.20
Smallpox infects only human beings. It has no animal reservoirs
and persists in the environment for only a short period, except when
properly prepared in a laboratory. Smallpox must be actively
infecting a human population to survive. It did not exist until human
beings reached a high enough density that it could spread from
community to community, often not returning until there was a new
generation of children or young adults who were susceptible to the
disease.2'
Since smallpox has no animal hosts and is not persistent in the
environment, it would be eradicated if at any point in time there were
no human beings infected. This became a theoretical possibility in
the 1951 when Collier developed a freeze-dried smallpox vaccine
12. Frank Fenner, et al., Smallpox and its Eradication 5 (History of
International Public Health No. 6, 1988), available at http://www.who.int/
emc/diseases/smallpox/Smallpoxeradication.html. This is the definitive work on
smallpox, compiled to "preserve for posterity" the story of the control of smallpox.
See also W.H. McNeill, Plagues and Peoples 160-65 (1976) (detailing how disease
really subdued the Aztecs, not the Spanish).
13. Fenner, supra note 12, at 49-50.
14. Joel G. Breman & Donald A. Henderson, Diagnosis and Management of
Smallpox, 346 New Eng. J. Med. 1300, 1302 (2002).
15. Id.
16. Id. The typical period is about ten days, but stretches out to three weeks
if the rash is slow to heal.
17. Id. The range is 37-88.
18. Fenner, supra note 12, at 5.
19. Breman & Henderson, supra note 14, at 1301.
20. Id.
21. Jonathan B. Tucker, Scourge: The Once and Future Threat of Smallpox 6
(2001).
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that could be stored at room temperature and thus could be easily
transported to remote locations.2 A Western Hemisphere smallpox
eradication program was started by the Pan American Sanitary
Organization in 1950.23 At the suggestion of the Soviet Union, the
World Health Organization began a worldwide eradication program
in 1967.4 This program combined intensive case finding and
contract tracing-looking for persons infected with or exposed to
smallpox-with mandatory vaccinations for all exposed persons.
On October 26, 1977, the last known naturally occurring smallpox
case was recorded in Somalia. In 1980, the WHO declared that
smallpox had been eradicated. The United States ended routine
smallpox vaccinations in 1972, and they were not routinely given
anywhere after 1983.5
Before eradication, many laboratories maintained stocks of the
virus for research purposes. After eradication, a laboratory accident
that led to a smallpox death reminded the world that these laboratory
stocks of virus had the potential to reintroduce smallpox into the
world.26 All the remaining stocks were destroyed, with the
exception of stocks maintained by the CDC in Atlanta and the Soviet
Union. There was an ongoing debate over destroying these
remaining stocks, until a defector who ran the Soviet Union's
biological warfare operations claimed that the Soviet Union had
produced thousands of pounds of smallpox virus in derogation of the
Biological Warfare Treaty.27 This claim has been impossible to
verify, and there is no information about the current whereabouts of
the virus if it was produced. This possible unaccounted-for
smallpox virus fuels fears of the virus getting into the hands of
terrorists.
22. Fenner, supra note 12, at 287.
23. Id. at 388-89.
24. Id. at 387.
25. Id. at 1265.
26. See id. at 1097. The victim, a 40-year-old woman, was "a medical
photographer in the Anatomy Department of the Medical School of the University
of Birmingham ... [who] became ill with fever, headache and muscular pains on
11 August [1978]." Id. She had last been vaccinated in 1966. Id. A rash
developed on August 15, and vesicles developed on August 24 (which "led to a
suspicion of smallpox"), and she was placed in an isolation hospital later that day.
Id. However, her health "deteriorated rapidly and she died on 11 September
[1978]." Id. The specifics of this outbreak are in Chapter 23, "Smallpox in Non-
endemic Countries." Id. at 1069-1101.
27. Terrorism and Intelligence Operations: Hearing Before the Joint
Economic Comm., 105' Cong. (1998) (statement of Dr. Kenneth Alibek, Former
Director, Soviet Union Offensive Biological Warfare Program), available at
http://www.house.gov/jec/hearings/intell/alibek.htm and http://biotech.law.lsu.edu/
blaw/bt/smallpox/Congress/Alibek01.htm.
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Smallpox epidemics have always been horrific events in human
history. 8 In most communities, however, the damage done by any
given epidemic was limited because many people would be immune
to the disease because of prior exposure. As vaccination became
more common in the late nineteenth century, it dramatically reduced
the number of persons infected during epidemics. This was critical
because the real threat of epidemic disease is not individual deaths,
but the collapse of society through fear and the loss of a critical mass
of infrastructure workers. The impact of such societal collapse can
be seen in the effect of an epidemic that is introduced into a society
with no immunity. When measles, which does not have a high
fatality rate, was introduced into native populations with no
immunity, everyone became sick at the same time.29 With no one to
nurse the sick, prepare food, or provide water, the disease sometimes
killed eighty percent or more of the community.3"
The eradication of smallpox, and the subsequent ending of
vaccinations, has left the world in a unique position. Smallpox
vaccination does not give life-long immunity, and approximately half
of the world's population has never been vaccinated. For the first
time since smallpox first attacked humankind, there is little natural
immunity. Eradication of natural smallpox and the cessation of
smallpox vaccination has put the whole world at risk for a massive
smallpox epidemic. Even the data used to estimate smallpox
transmission is suspect because it was derived from populations with
significant immunity.3' We have no good information about the
28. Fenner, supra note 12, at vii.
29. William H. McNeill, Plagues and Peoples (1976); J.V. Neel, W.R.
Centerwall, N.A. Chagnon, & H.L. Casey, Notes on the Effect of Measles and
Measles Vaccine in a Virgin-Soil Population of South American Indians, 91 Am.
J. Epidemiology 418 (1970):
The impact of measles on a primitive population is well known. It seems
to have been generally assumed that this is a result of a greater
'constitutional' susceptibility. However, in 1877 Squire (1) describing the
collapse of village life during an epidemic of measles in Fiji, clearly
presented a contrary view: "Excessive mortality resulted from terror at the
mysterious seizure, and the want of commonest aids during illness; there
were none to offer drink during the fever, nor food on it subsidence.
Thousands were carried off for want of nourishment and care as well as
by dysentery and congestion of the lungs. We need to invoke no special
susceptibility of race of peculiarity of constitution to explain great
mortality."
30. For an example of the same effect from an outbreak of smallpox, see
Fenner, supra note 12, at 175 ("[E]pidemics in previously unexposed subsistence-
farming populations appeared often to have produced much higher mortalities than
those seen in Asia [20% or more fatality in unvaccinated persons], owing to the
social disruption and consequent starvation that they caused.").
31. See Martin I. Meltzer, et al., Modeling Potential Responses to Smallpox as
2004]
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dynamics of the spread of smallpox in a large, dense, community
with no immunity. 32 Depending on the assumptions made about the
a Bioterrorist Weapon, 7 Emerging Infectious Diseases 959 (2001), available at
http://www.cdc.gov/ncidod/EID/vol7no6/meltzer.htm. The base rate information
used by Meltzer was from Fenner, supra note 12. Of course all of the earlier data
was from populations long exposed to smallpox, so many, if not most, of the
general population had lived through earlier outbreaks. Moreover, the model only
assumed three persons infected per infectious person. However, any smallpox
epidemic now would likely progress at a far higher rate than the historical rates
since virtually no one born after 1972 in the United States (or after 1980 in the rest
of the world) has immunity from previous exposure to the disease. Additionally,
the older adults who have not been vaccinated in the last thirty years are unlikely
to retain sufficient lingering protection from their earlier inoculations as children
or young adults. Meltzer attempted to compensate for the unknown degree of
residual smallpox protection from older Americans (older than thirty) previous
vaccinated in their youth by
assum[ing] an unlimited supply of susceptible persons, so that disease
transmission will not be halted because of lack of susceptible persons.
Although this scenario is unrealistic for modeling the natural spread of an
infectious disease, it may be realistic for considering the initial spread of
an infectious disease after deliberate infection of a small number of
persons in a population with a relatively large proportion who are
susceptible.
Id. at 961.
Of course, for almost all of human history, the "natural" spread of human disease
was essentially limited by how far a sick person could walk. In an age when an
infectious person can reach any spot on Earth in 24 hours, and do so repeatedly
during the 10-12 days of prime infectious capability, the "natural" spread rate
would be much higher. Fenner deals with this precise situation. Fenner, supra note
12, at 202, 1077-79.
32. The limited data we do have suggests the vulnerability of unprotected
societies could be both quite severe and difficult to predict or control. For example,
Fenner's comprehensive history of the eradication of smallpox gives a revealing
illustration of the problem. Fenner, supra note 12. In 1970, a German hospital in
Meschede admitted an electrician into its isolation ward ten days after his return
from Pakistan with a "feverish illness ... suspected to be typhoid fever." Id. at
192-93. Three days later, he developed a rash, confirmed, using an electron
microscope, to the smallpox two days later. Id. At that time, after five days in the
general hospital in full isolation, the patient was transferred to a specialized
smallpox hospital. Id. Despite the "rigorous isolation of the patient" and "the
vaccination of all of the patients and nurses in the general hospital," nineteen
additional cases of smallpox resulted from the electrician's admission. Id. Several
aspects of this event are quite chilling. The electrician was only on the first floor,
yet persons on all three floors of the hospital developed smallpox. Id. One person,
case 8, visited the ground floor of the hospital only once, fourteen days after the
electrician was admitted, for no more than fifteen minutes. Id. Smoke tests
performed by investigators of the outbreak revealed that eleven cases were in rooms
outside of the smoke's flow pattern; two cases upwind of the smoke pattern. Id.
Case 17 developed twenty-one days after the electrician's admission and case 19
developed fourteen days after a visit to case 17. Id. Perhaps the most sobering
aspect of the Meschede outbreak is the contrast between the results of a fleeting
exposure in an unprotected population with the results of prolonged exposure in a
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speed with which smallpox would spread in such a community, many
people believe there is a chance for a global pandemic that could
disrupt modem society.33 It is this fear that makes smallpox the most
frightening bioterrorism agent.
Based on the potential damage from an outbreak, one could make
a strong argument for smallpox vaccinations, even if there is
significant risk of adverse reactions to the vaccine. For example,
whatever tort liability might attach because of complications of
vaccinations in health care workers or patients would be dwarfed by
the catastrophic losses a hospital would face during a large scale
outbreak of smallpox. The key to the risk calculus is the probability of
an outbreak. Prior to 1999, the public health establishment was so
convinced that the remaining smallpox virus was under proper control
that they debated destroying the virus in the authorized research labs
to assure that there would not be any more virus in the world, despite
the fact that the information about the Soviet smallpox virus
manufacture was given to national security agencies in 1993. Since the
White House made no claims that the risk of smallpox bioterrorism
had increased, it was not irrational for health care institutions to work
on the assumption that the chance of an outbreak in their community
was very small. Given that smallpox vaccine, as discussed below, is
by far the most dangerous vaccine available, the low probability of an
outbreak made the risk of vaccine-related injuries much more probable.
IV. THE HISTORY OF SMALLPOX VACCINATIONS
Persons who survive smallpox develop immunity to the disease,
which lasts for many years. Observing this led those who sought to
fight the disease to find ways to inoculate the population
("variolation"). In ancient China, a powder was developed to be
inhaled.34 In India, skin was inoculated with the contents of smallpox
pustules. 35 These tactics, which were employed erratically over the
centuries, lessened the severity of infections, but variolation
transmitted the disease and often resulted in a fatal illness.
Furthermore, those inoculated could transmit smallpox to others.
protected population. Fenner observed: "Especially in India, long-distance
movements by train or bus of patients suffering from smallpox, with an overt rash,
used to occur frequently, yet infection of casual fellow-travellers [sic] was rare
indeed-so rare that instances of it were deemed unworthy of special report." Id.
at 191. Here, while contained in a controlled, isolated hospital room, one sick
person infected nineteen more with smallpox, more than six times the 3:1 infection
ratio assumed in the Meltzer model. Meltzer, supra note 31.
33. Tara O'Toole, Michael Mair, and Thomas V. Inglesby, Shining Light on
"Dark Winter, " 34 Clinical Infectious Diseases 972, 975 (2002).
34. Fenner, supra note 12, at 252-53.
35. Id. at 253.
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In the late eighteenth century, the English physician Edward
Jenner observed that dairymaids who had been infected with cow ox,
a mild pustular infection, thereafter were immune to smallpox. ° In
1796, Jenner inoculated a young man with cowpox, and the boy
developed smallpox immunity.37 This led to widespread inoculation
with cowpox starting in the nineteenth century. Genetic analysis
indicates that since that time, the virus used for inoculation has been
replaced by another virus called vaccinia, which is not cowpox nor
any other known pox virus.38 (It may be the now extinct horsepox,
or a hybrid of horsepox and cowpox.) A person who is infected with
vaccinia develops immunity to smallpox, but this immunity is not as
effective as that from being infected by smallpox. While smallpox
infection confers lifelong immunity on those who survive, those who
are vaccinated with vaccinia have to be revaccinated every five to ten
years to keep up their immunity, and need to be vaccinated again
when exposed to smallpox.39
The effectiveness of vaccination led states to adopt laws in the
nineteenth century making it compulsory.4° However, there is a long
history of opposition to such laws in the United States.4 The leadin
United States Supreme Court case Jacobson v. Massachusetts
involved a defendant who refused to be vaccinated. This refusal was
not as unreasonable as it might seem at first glance: the vaccine was
often contaminated with bacteria and other viruses, making the
traditional immunization process dangerous. Still, Jacobson was
prosecuted criminally for violation of the law and regulations of the
Board of Health of Cambridge, Massachusetts.43 He was found
guilty, and appealed to the Massachusetts Supreme Judicial Court,
36. Id. at 258.
37. Edward Jenner, The Three Original Publications On Vaccination Against
Smallpox (1798), available at http://www.fordham.edu/halsall/mod/1798jenner-
vacc.html and http://biotech.law.lsu.edu/cphl/history/articles/jenner.htm.
38. Tucker, supra note 21, at 37.
39. Fenner, supra note 11, at 175.
40. See Allegany County Com'rs v. McClintock, 60 Md. 559 (1883); City of
Ft. Wayne v. Rosenthal, 75 Ind. 156 (1881); Schmidt v. Rd. of County Com'rs of
Steams Co., 24 N.W. 358 (Minn. 1885); Scripps v. Foster, 3 N.W. 216 (Mich.
1879); Mclntire v. Town of Pembroke, 53 N.H. 462 (1873); Com. V. Pear (66 N.E.
719 (Mass. 1903), aff'd by Jacobson v. Commonwealth of Massachusetts, 197 U.S.
11,25 S. Ct. 358 (1905); Carrv. Bd. of Educ. Of Columbus, 1 Ohio N.P. (n.s.) 602
(Ohio Com. P1. 1903).
41. MacLeod, Law, Medicine and Public Opinion: The Resistance to
Compulsory Health Legislation, 1870-1907 (1967).
42. Jacobson v. Commonwealth of Massachusetts, 197 U.S. 11, 25 S. Ct. 358
(1905), available at http://biotech.law.lsu.edu/cases/vaccines/
Jacobson v Massachusetts.htm.
43. Id. at 13, 25 S. Ct. at 359.
[Vol. 64860
2004] EDWARD P. RICHARDS 861
which upheld the conviction." In an appeal to the Supreme Court,
Jacobson argued that the compulsory vaccination violated the
Preamble to the United States Constitution and the spirit of the
Constitution.45
The Supreme Court, in an opinion by the first Justice Harlan,
invoked the traditional police power by which legislatures establish
regulations to protect the public health and safety.46 There is no
absolute right, the Court said, to be free of all restraint. 4 It was
appropriate, according to the Court, for the Massachusetts legislature
to refer the issue of what is necessary for the public health and safety
of a city to the Board of Health, and under such circumstances, the
Court stated that it would not adjudge unnecessary the Board's
vaccination requirement.48 The Court declared:
We are not prepared to hold that a minority, residing or
remaining in any city or town where smallpox is prevalent,
and enjoying the general protection afforded by an organized
local government, may thus defy the will of its constituted
authorities, acting in good faith for all, under the legislative
sanction of the state.
With regard to the defendant's offer to prove that the vaccine often
injured those vaccinated, the Court pointed out that "The legislature
assumed that some children . . . might not be fit subjects of
vaccination, and it is suggested-and we will not say without
reason-that such is the case with some adults."" But Justice Harlan
noted that Jacobson never had offered to prove that he himself was
not a fit subject of vaccination.5' The opinion went on to state that to
exempt the defendant because the vaccine often injured people
would mean that compulsory vaccination could not in any
conceivable case be legally enforced in a community, even at
the command of the legislature, however widespread the
epidemic of smallpox, and however deep and universal was
the belief of the community and of its medical advisers, that
a system of general vaccination was vital to the safety of all.52
After Jacobson, requiring vaccinations as a prerequisite for
children to attend school became common. Today, most-though not
44. Id. at 21, 25 S. Ct. at 359.
45. Id. at 22, 25 S. Ct. at 359-60.
46. Id. at 24, 25 S. Ct. at 360-61.
47. Id. at 26, 25 S. Ct. at 361.
48. Id. at 27, 25 S. Ct. at 362.
49. Id. at 37, 25 S. Ct. at 366.
50. Id. at 36, 25 S. Ct. at 365.
51. Id. at 36-37, 25 S. Ct. at 365-66.
52. Id. at 37, 25 S. Ct. at 366.
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all-states prohibit school-age children from public or private
educational facilities without having undergone the prescribed
immunizations (though some states permit children to attend school
while they are in the process of obtaining their immunizations).
Over time, religious exemptions from compulso 7V immunization
have been sought. In Prince v. Commonwealth,5 parents raised
religious objections to vaccination, citing the first amendment
protection of the free exercise of religion. 4 The Supreme Court
ruled against them:
Acting to guard the general interest in youth's well being,
the state as parens patriae may restrict the parent's control by
requiring school attendance, regulating or prohibiting the
child's labor and in many other ways. Its authority is not
nullified merely because the parent grounds his claim to
control the child's course of conduct on religion or
conscience. Thus, he cannot claim freedom from
compulsory vaccination for the child more than for himself
on religious grounds. The right to practice religion freely
does not include liberty to expose the community or the child
to communicable diseases or the latter to ill health or death.55
Quite a few states have enacted statutes that provide exemptions
from the requirement that children must be immunized to attend
school.56 Such exemptions can derive from religious beliefs and
practices, from the possibility that immunization might endanger a
child's life or health, and from personal beliefs. Where such
exemptions exist, states may take action in the event of an epidemic
for which a child is not immunized: the child maybe suspended or
excluded from school until the outbreak is over,5 the child may be
53. 321 U.S. 158, 64 S. Ct. 438 (1943).
54. Id.
55. Id. at 166-67, 64 S. Ct. at 442.
56. Only Mississippi and West Virginia provide no religious exemption; the
other forty-eight states do. Seventeen states currently provide for non-religious
exemptions based upon either moral or philosophical objections. James G. Hodge,
Jr. & Lawrence 0. Gostin, School Vaccination Requirements: Historical, Social,
and Legal Perspectives, 90 Ky. L.J. 831, table 2 (2002). The fifteen states with
moral/philosophical objections found by Hodge in 2002 were Arizona, California,
Idaho, Indiana, Louisiana, Maine, Michigan, Minnesota, Nebraska, North Dakota,
Ohio, Oklahoma, Vermont, Washington, and Wisconsin. Id. at 869-73. Two states
added this exception in 2003: Arkansas and Texas. John Kasprak, Exemptions
From Childhood Immunization Requirements (OLR Res. Rep. 2004-R-0263, 2004),
available at http://ww.cga.ct.gov/2004/rpt/2004-R-0263.htm.
57. Centers for Disease Control and Prevention, Postexposure Prophylaxis,
Isolation, and Quarantine to Control an Import-associated Measles
Outbreak-Iowa, 2004,53 MMWR 969 (2004), available at http://biotech.law.lsu.
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quarantined, 8 or the child may be required to be vaccinated despite
religious objections.59
State courts have varied in how they deal with religious
exemptions to immunization requirements. In Cude v. State,6" where
a parent had kept his eight children out of school because of his
refusal to have them vaccinated, the Arkansas Supreme Court upheld
the constitutionality of an order turning children over to the Child
Welfare Division of the state welfare department to have them
vaccinated so that they could attend school.6' Other courts have
recognized that the legislature has the right to create a religious
exemption.62 Equal protection issues have also been raised. A
statute that allowed exemptions only to members of a recognized
church or denomination was struck down as improperly excluding
those who do not belong to such a church.63 Legislatures have
responded by allowing exemptions from compulsory immunization
for people who have strongly held beliefs, but who do not belong to
any established or organized denomination.' Some states have even
edulcases/pp/mm5341 a.pdf.
58. Id.; see also Iowa Admin. Code r. 641-1.9(135,139A) (2004).
59. See Miss. Code Ann. § 41-23-37 (2002); W. Va. Code § 16-3-4 (2002).
The religious exemption formerly in Mississippi's statute was struck down in
Brown v. Stone, 378 So.2d 218 (Miss. 1979). The exemption discriminated against
children "whose parents have no such religious convictions." Id. at 223.
60. 377 S.W.2d 816 (1964).
61. Id. The central ruling of this case-that the vaccination requirement is a
proper exercise of the police power which will withstand a religious
challenge-was reaffirmed one year later in Wright v. Dewitt School District, 385
S.W.2d 644 (1965), available at http://biotech.law.lsu.edu/
cases/vaccines/wright.htm. The following year the Arkansas Court found that
failure to comply with mandatory vaccination laws was neglect under the child
welfare laws. Manis v. State ex rel. DeWitt School Dist. No. 1, 398 S.W.2d 206
(1966). More generally, the Supreme Court has allowed police power regulations
that interfere with religious practices if they are reasonably related to the public
health and safety. Employment Div., Oregon Dep't of Human Res. v. Smith, 494
U.S. 872, 881, 110 S. Ct. 1595, 1601 (1990).
62. See Sherr v. Northport-East Northport Union Free Sch. Dist., 672 F. Supp.
81 (E.D.N.Y. 1987); Kleid v. Bd. of Educ., 406 F. Supp. 902 (W.D. Ky. 1976).
63. Dalli v. Bd. of Education, 267 N.E.2d 219 (1971).
64. These exemptions are undermining vaccination rates in some communities.
They pose a special risk when unvaccinated children congregate in the same
schools, as frequently happens because their parents share common beliefs. For
example, Dr. Diane Griffin, Chair of the Department of Molecular Microbiology
and Immunology at Johns Hopkins University's Bloomberg School of Public
Health in Baltimore, agrees that outbreaks of contagious diseases, such as measles,
"in other areas of the world pose a risk to the United States .... In Colorado, for
example, there are communities 'where close to 20 percent of kids are not
immunized .... All you need is the introduction of a case and since its [sic]
constantly happening in the United States all you need is a case to occur in those
vulnerable communities' for an epidemic to take hold...." Steve Mitchell, U.K.
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allowed exemptions for non-religious philosophical objections to
vaccination. 65  As viewed by Steve P. Calandrillo, a "variety of
factors are at play: religious and philosophical beliefs, freedom and
individualism, misinformation about risk, and overperception of
risk.' 66  Some observers find comfort in the fact that overall
immunization rates remain quite high.67 Regrettably, however, the
combinations of relaxed immunization requirements and a self-
selected small, dense group of unprotected people all too often
produce "exemption clusters" which can lead to disease. 68  As
Calandrillo so aptly points out, we simply must appreciate and
"distinguish ... the significance between nationwide versus local
Measles Outbreaks Pose Risk to U.S., UPI, Oct. 31, 2003. For a stark example of
such an event, consider the 1994 measles outbreak originating at the Breckenridge
ski resort in Colorado and subsequently intensely spread through two Christian
Science religious communities in Illinois. For details, see Centers for Disease
Control and Prevention, Interstate Measles Transmission from a Ski Resort-
Colorado, 1994,43 MMWR 627 (1994), available at http://www.cdc.gov/mmwr/
PDF/wk/mm4334.pdf.
65. As of September 2004,20 states allow, explicitly or by implication, parents
to not immunize their children solely upon moral or philosophical grounds. For a
comprehensive listing of each state's specific statutes and exemptions as of late
2001, see Hodge & Gostin, supra note 56, at 869-73, table 2. Since then, two
states have amended their statutes to allow philosophical objections by parents to
override immunization laws. Texas amended its statute to add an exception "for
reasons of conscience" in addition to "because of the person's religious beliefs."
Tex. [Educ.] Code Ann. § 38.001 (f) (2004), as amended by 2003 Texas Sess. Law
Serv. Ch. 198, § 2.160 (Vernon). Similarly, Arkansas amended its statute to read
"[t]he provisions of this section shall not apply if the parents or legal guardian of
that child object thereto on the grounds that immunization conflicts with the
religious or philosophical beliefs of the parent or guardian." Ark. Code Ann. § 6-
18-702(d)(4)(A) (Michie 2004), as amended by 2003 Ark. Acts 999.
66. Steve P. Calandrillo, Vanishing Vaccinations; WhyAre So ManyAmericans
Opting Out of Vaccinating Their Children?, 37 U. Mich. J.L. Reform 353, 353
(2004).
67. For example, a senior staff attorney in Connecticut's Office of Legislative
Research cites Hodges' finding that "exemption rates range from 1% to 2.8% C... in]
Arizona, California, Idaho, Indiana, Maine, Minnesota, Montana, Pennsylvania,
Rhode Island, Utah, Vermont, and Wyoming." Kasprak, supra note 56. His source
was a shortened version (also prepared by James G. Hodge, Jr.), of Hodge and
Gostin's original article from the 2002 Kentucky Law Journal. See Hodge & Gostin,
supra note 56. Kasprak updated his state exemptions table to February, 2004, from
the similar table in a State Legislative Report Hodge wrote for the National Council
of State Legislatures. James G. Hodge, Jr., School Vaccination Requirements: Legal
and Social Perspectives, 27 NCSL State Legislative Report No. 14,4-6 (Aug. 2002),
available at http://www.ncsl.org/programs/health/schoolvaccination.pdf.
68. Calandrillo, supra note 66, at 422. "Religious exemptions to vaccination
in Amish, Mennonite and Christian Science communities are responsible for the last
two major outbreaks of polio in America." Id. In fact, "nearly every major
outbreak of vaccine-preventable diseases in the last 25 years has occurred among
members of those [Amish and Christian Science] denominations." Id. at 415.
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exemption rates," because, although "nationwide immunization rates
are still quite high overall," a concentration of exemption "can hide
areas where exemptions are dramatically higher than overall averages
indicate, making it possible for disease pockets to spring up. ' 69 As a
result, local exemption rates take on great significance.
V. CONTEMPORARY SMALLPOX VACCINE
The smallpox vaccine that is currently available, and the one used
for the smallpox vaccination campaign, is called Dryvax®,
manufactured by Wyeth. 7' It is the same vaccine that was developed
during World War II, and the most recently produced lots have been
in storage for more than thirty years.72 It contains live vaccinia. 7'3
Smallpox vaccine contains live virus because a person must be
infected with vaccinia to develop immunity to smallpox. There is a
new way of manufacturing the vaccine using cell culture that produces
a vaccine with less contamination than the process used for making
DryVax®, but it poses the same risks because it uses the same live
virus.74 (Dead virus vaccine has been tried, but it does not work.75)
69. Id. at 421-22.
70. Id. at 422. For example, Kasprak noticed the rise in total exemptions, the
rate of increase in exemptions, and the occurrence of concentrated exemptions:
Colorado, which has the lowest vaccination coverage rate in the
country, has seen a significant increase in exemption rates, from 0.3% of
kindergarteners to 3% over a 10-year period. Michigan's exemption rate
is almost 6%, or more than 7,500 kindergarten-aged children.
Washington's exemption rate has increased from 3.4% of kindergarten-
aged children five years ago to a current level of 4.1% (about 2,400
children.
Oregon's number of exemptions has doubled since 1999, with the bulk
of this due to an increase in religious exemptions. In particular, Ashland,
a small city in Jackson County, Oregon, has a high rate of religious
exemptions. In school year 2000-2001, 11% of school children in
Ashland had a religious exemption to vaccination, compared to 3% for all
of Jackson County and 2.7% for the state.
Kasprak, supra note 56, at 5.
7 1. Press Release, American Home Products Corp., American Home Products
Submits Plan to Produce Smallpox Vaccine (Oct. 26, 2001), available at
http://www.wyeth.comlnews/Pressed andReleased/prl0_262001.asp?archive
=2001.
72. Wyeth-Ayerst Laboratories, a division of American Home Products
Corporation, began manufacturing a vaccinia (smallpox) vaccine, DryVax®, in
1944. Id.
73. DryVax® Package Insert, supra note 11.
74. Sharon E. Frey, et al., Dose Related Effects of Smallpox Vaccine, 346 New
Eng. J. Med. 1275 (2002); Steven R. Rosenthal, Michael Merchlinsky, Cynthia
Kleppinger, and Karen L. Goldenthal, Developing New Smallpox Vaccines, 7
Emerging Infectious Diseases 920, 922 (2001).
75. E.R. Freed, et al., Vaccinia Necrosum and Its Relationship to Impaired
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The objective of vaccination is to produce a small infected sore
on the patient's arm. To vaccinate a patient, a drop of solution
containing vaccinia is put between the prongs of a very small two-
pronged needle, which is then punched into the patient's arm multiple
times. This infects the person's skin with vaccinia. For most
persons, the infection is limited to a small sore at the vaccination
site, but the infection can be spread by scratching or other trauma.77
As many as one-third of vaccinated persons suffer fever and malaise
sufficient to interfere with work or recreation, but most of these
persons recover quickly without permanent sequelae. 8 The sore lasts
about two or three weeks and leaks live virus from the surface.79 If
a person scratches the sore and then scratches his/her eye or nose, or
an insect bite or scratch, the virus will form sores at the scratched
location. The virus can also be spread to others who come into
contact with the sore or its dressing. Most authorities assumed that
people without severe vaccinia complications do not spread the
vaccinia virus by coughing, but this is not clear since it has never
been carefully studied. This did not matter, of course, when everyone
was immunized.
Part of the recommendation for caring for individuals who have
been vaccinated is that the vaccination should be covered with a
bandage and long sleeves should be worn to cover the bandage.80
This is to prevent the virus from spreading to other parts of the body
or to other people. The recommended bandage is a combination of
gauze to absorb the fluids from the vaccination sore and a covering
that will keep these fluids and the virus they contain from getting out
of the bandage.8 The problem is that the sore needs to dry out in
order to heal properly and any bandage that keeps the virus from
getting out will keep the sore wet. In practice, there is only one way
to keep a wet sore covered and dry for long periods of time: the
bandage has to be changed every time it gets wet, sometimes several
times a day. This involves more work and more potential spread of
vaccinia than the recommendations acknowledged. There was81
documented secondary spread among the military vaccinees. While
this was relatively rare, hospitals and health care are a much more
Immunologic Responsiveness, 52 Am. J. Med. 411 (1972). This article discusses
the use of killed virus to screen for antibody response because it cannot cause
infection. Id. There is no other discussion of the use of killed virus in the modem
literature.
76. DryVax® Package Insert, supra note 11.
77. Id; CDC, Guidance II, supra note 9.
78. CDC, Guidance II, supra note 9.
79. Id.
80. Id.
81. DryVax® Package Insert, supra note 11.
82. CDC, Secondary and Tertiary Transfer of Vaccinia Virus, supra note 5.
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conducive environment for transmission. s3 There also have been
anecdotal reports that vaccinations covered with the recommended
occlusive bandage are creating larger vaccination sores ("robust
takes") which may heal more slowly and leave more scarring than
those that are properly covered with simple gauze that allows the sore
to dry and heal more effectively, but which does not prevent the
spread of vaccinia as well.
VI. VACCINE COMPLICATIONS
Smallpox vaccinations have many complications. One of the
most common serious sequelae is the spreading of the vaccination
sore, leading to the development of sores on other parts of the body.84
This can happen in people with eczema and other skin conditions.
While not usually life-threatening, this is a painful, difficult to treat
complication that can leave the patients permanently scarred. Others
suffer neurologic sequelae, which can be permanent or even fatal in
a small percentage of cases. When the virus spreads from the
original vaccination sore, the risk of infecting others with vaccinia
through secondary spread is dramatically increased. Such persons
must be managed so that they are never in contact with unvaccinated
persons or persons who are susceptible to vaccinia injury. If they are
treated in health care facilities or hospitals, they must be put in
proper isolation and managed much as a smallpox case is managed.
The most predictable complications are those secondary to
immunosuppression. Since the smallpox vaccine depends on
infecting the vaccinee with vaccinia, it is not surprising that persons
with immunosuppression are at particular risk of having this usually-
minor infection spread. The most serious complication is
disseminated vaccinia.86 Disseminated vaccinia means that the
immunized person's immune system could not keep the vaccinia
virus confined to the vaccination sore. The virus spreads as a whole
body illness, creating sores that look very much like smallpox.
Disseminated vaccinia is often fatal. It was very rare in the 1960s
and early 1970s when the last smallpox vaccinations were done in the
United States, accounting for about one death per million
immunizations.8 7 Studies at the time found that such cases could
83. Id.
84. Donald A. Henderson, et al., Smallpox as a Biological Weapon: Medical
and Public Health Management, 281 JAMA 2127, 2134 (1999).
85. Id.
86. There is some confusion about the nomenclature. Disseminated vaccinia
in this review means the generalized spread of vaccinia throughout the body.
87. Steven M. Gordon, Pre-Event Smallpox Vaccination: Unresolved Issues,
70 Cleveland Clinic J. Med. 80,81 (2003).
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usually be traced to persons with defective immune systems. More
importantly, the leading study determined that persons with defective
cellular immunity were usually killed by the vaccine.88
The only specific treatment for disseminated vaccinia is human
vaccine immunoglobulin (VIG) which is made from the serum of
persons recently vaccinated with smallpox vaccine.89 There was very
little VIG available when the smallpox vaccination campaign was
announced. The government increased production as quickly as
possible, but there was a serious question of whether there would
have been enough VIG to treat the expected complications from
vaccinating 1,000,000 persons over a few months.9° The amount of
available VIG has never been revealed to the general public. While
there are no antiviral drugs that are known to treat vaccinia, there are
drugs that are effective against other pox viruses, and it is hoped
these will help cure vaccinia reactions. The lack of effective
treatments contributed to the fear of vaccine injuries.
In 1972, the last year when smallpox vaccinations were routinely
given in the United States, there were very few persons with such
immune system defects. Most were children with genetic diseases,
with the most severely affected dying shortly after birth because they
could not fight off any infections.91 The others tended to be persons
with undiagnosed cancers who were inadvertently vaccinated. Since
1972, the use of powerful cancer drugs, arthritis drugs, and transplant
drugs, plus the emergence of HIV/AIDS, has increased the number of
immunosuppressed persons. There are at least 100 times as many
immunosuppressed people in the United States today as in 1972 and
perhaps 1000 times as many.92
We have little direct information on the consequences of
vaccinating persons with pharmacologically-suppressed immune
systems or those suffering from HIV. There is one case reported in
the literature where a person with HIV was immunized with smallpox
vaccine.93 The victim was a healthy nineteen-year-old soldier who
been tested and found to have normal blood work before
immunization. 94 This was just before the HIV screening test was
used for all military personnel (one of the results of this case).
88. Freed, supra note 75.
89. Henderson, supra note 84, at 2132.
90. Id.
91. Probably the best known case (Severe Combined Immunity Deficiency
Syndrome) was David Vetter, the "bubble boy," who died in 1984, at 13. See Steve
McVicker, Bursting the Bubble, Houston Press, April 10, 1997, at 10-20, available
at http://www.houstonpress.com/issues/ 1997-04-1 0/feature.html.
92. Gordon, supra note 87, at 81-82.
93. R.R. Redfield, et al., Disseminated Vaccinia in a Military Recruit With
Human Immunodeficiency Virus (HIV) Disease, 316 N. Engl. J. Med 316, 673.
94. Id.
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Within three weeks of vaccination, the soldier developed
disseminated vaccinia" Despite intensive treatment, including many
injections with VIG, he died after a prolonged illness.96 It appeared
that the vaccinia virus destroyed the reserve capacity of the patient's
immune system, leading to a rapidly progressive case of AIDS . His
vaccinia did appear to resolve before his death.98 Given the lack of
knowledge about AIDS and HIV at the time, and the unavailability
of modem anti-HIV drugs, it is unknown whether he would have had
the same course with modem aggressive treatment.
Taken together, these two studies, plus the other work literature,
must be read as indicating that immunizing or exposing a person with
a cellular immunity defect such as HIV to smallpox vaccine has a
high probability of serious illness and death. It has been informally
reported that many military personnel with HIV were vaccinated
without these side-effects. If true, these data should be made
available to help health care workers and others make an informed
decision about accepting vaccination. At this writing, these cases
have still not been published, and they were not available at the time
health care providers were asked to volunteer for smallpox
vaccinations. This led to great uncertainty about the risk of vaccine
to the general population, which, unlike the military, had not been
screened to eliminate immunosuppressed persons.
As the vaccinations progressed, it was discovered that several
vaccinees suffered symptoms of cardiac disease, and three died.99
This unexpected complication, occurring in a relatively small
population of civilian vaccinees, marked the end of the government's
active support of the vaccination of civilian volunteers. While the
program was not cancelled, there were few additional persons
vaccinated. A retrospective study of cardiac deaths in New York
City during the last mass vaccination program for smallpox in 1947
showed no excess cardiac deaths."° Given the high prevalence of
cardiac illness in the general population, as represented by the
civilian volunteers, it is likely that this cardiac illness was not vaccine
related, but this is very difficult to prove.
95. Id.
96. Id.
97. Id.
98. Id.
99. Centers for Disease Control and Prevention, Update: Cardiac and Other
Adverse Events Following Civilian Smallpox Vaccination-United States, 2003, 52
MMWR 639 (2003), available athttp://www.cdc.gov/mmwr/PDF/wk/mm5227.pdf
and http://biotech.law.lsu.edu/cdc/mm5227.pdf#page= 11.
100. Centers for Disease Control and Prevention, Cardiac Deaths After a Mass
Smallpox Vaccination Campaign-New York City, 1947, 52 MMWR 933 (2003),
available at http://www.cdc.gov/mmwr/PDF/wk/mm5239.pdf and
http://biotech.law.lsu.edu/cdc/mm5239.pdf [hereinafter CDC, Cardiac Deaths].
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VII. LEGAL LIABILITY FOR VACCINE COMPLICATIONS
This section reviews the potential liability for vaccine-related
injuries in the absence of any legal immunity under the Homeland
Security Act.'' Immunity under the Act is discussed in a later
section.
The first level of risk involves the primary immunization of
hospital personnel. It is likely that state worker's compensation laws
will require employers to pay worker's compensation for all vaccine-
related injuries to their employees who are participating in the
vaccine program at the hospital's request. Workers who are
vaccinated as part of their military duty will be covered by the
military's benefits program. Workers at hospitals who do not
participate in the vaccination plan but who are vaccinated elsewhere
may not be covered by worker's compensation and may not have any
source of compensation if they are injured. The CDC
recommendations did not include any medical testing to screen
employees for immunosupressive disease or other contraindications
before vaccinating them." They were given a questionnaire about
conditions such as HIV and cancer, and the decision to vaccinate was
based on this self-reporting. Worker's compensation claims could be
significant if a person with contraindications to vaccination is
inadvertently immunized. There are conflicting reports about
whether the vaccine is contaminated with latex, which would pose a
significant risk to health care workers with latex allergies.'0 3 Some
worker's compensation insurance plans have questioned whether they
will cover vaccine-related injures because they are part of a national
defense program rather than a workplace activity. Irrespective of
whether the insurance carrier pays the claim, the employer will
probably be liable for the compensation.
If hospital personnel vaccinate any non-employees, the hospital
will be open to the full spectrum of medical malpractice tort liability,
in particular failure of informed consent and failure to screen
adequately before vaccination. Smallpox vaccine was classified as an
investigational new drug (an experimental drug) until recently."° In
the clinical trials being conducted with the vaccine, all persons are
101. Homeland Security Act, Pub. L. No. 107-296, 116 Stat. 2135 (2002),
available at http://biotech.law.Isu.edu/blaw/bt/smallpox/hlsfinal.htm.
102. See CDC, Guidance II, supra note 9.
103. DryVax® Package Insert, supra note 11.
104. Letter from Jerry P. Weir, Ph.D, Director, Office of Vaccines Research and
Review, Center for Biologics Evaluation and Research, Public Health Service, Food
and Drug Administration, to Amy J. Criswell, Wyeth Laboratories, Inc. (October
25, 2002), available at http://biotech.law.Isu.edu/blaw/bt/smallpox/
DRYVAX-approval.htm.
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tested for HIV, their medical histories are screened, and their family
members' medical conditions are evaluated. While DryVax® is now
an approved drug, the level of screening done in the clinical trials
arguably sets the standard of care for pre-vaccination screening.
Doing any less for routine immunizations is arguably malpractice.
This is a critical issue because many persons do not know that they
are immunosuppressed. For example, the CDC has estimated at
various times that twenty-five percent to fifty percent of persons
infected with HIV do not know they are infected.' °5 Given the
potential risks from inappropriate immunization, every person should
be tested for immune system problems before vaccination. The CDC
has not required this in its Smallpox Vaccination Recommendations
(updated October 21, 2002),106 which makes it difficult for hospitals
to require it because of various state privacy laws and anti-HIV
screening laws. However, an immunosuppressed person who
suffered a vaccine injury could still sue for both improper screening
and improper informed consent about the risks of vaccination.
The second level of risk involves the spread from an immunized
person to an unimmunized person. When smallpox vaccination was
performed routinely, such transmission was common. Vaccinia can
be transferred to anyone the vaccinated person has close contact with.
This can be a family member or fellow worker. Every person who is
vaccinated should be counseled and educated about the possible risks
to family members and significant others. If there is any question of
risk, a public health investigator should review the situation and visit
those in close contact.
The largest group at risk are patients in the hospital, especially
those who are immunosuppressed. If a health care worker infects a
patient with vaccinia, the patient can sue the health care worker and
the employer for negligence, in the absence of any protections from
the Act.'r The FDA warning label for the vaccine will make it hard
to defend such claims. 108
The third level risk is spread from a secondary case of vaccinia
to other third parties. A person with wide-spread vaccinia lesions
secondary to eczema or disseminated vaccinia sheds large amounts
of virus and is a significant risk to unimmunized persons, especially
those with immunosuppression. Persons caring for vaccine
complications must be immunized and must follow usual infection
105. See Centers for Disease Control and Prevention, Division of HIV/AIDS
Prevention, Quick Facts: Rapid Testing, April 2003-April 2004, at
http://www.cdc.gov/hiv/rapid testing/materials/QuickFactApril2004.htm.
106. CDC, Guidance 11, supra note 9.
107. See infra Part VIII (discussing a hospital's decision whether to furlough
employees).
108. DryVax® Package Insert, supra note 11.
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control guidelines. These patients must be kept away from all
immunosuppressed persons, both family members and other patients
in the hospital. This will be easy if they are sick enough to require
hospitalization because they can then be put in a negative pressure
isolation room. Many will not be very sick, but may have large and/or
multiple vaccine sores which will shed virus. They need to be very
carefully managed, with the help of the health department, to assure
that they do not come in contact with any immunosuppressed persons.
It may be best to require that initial management of all vaccine
complications be done at the health department rather than at the
hospital, and that persons needing more intense care be sent to one
designated facility which can set up appropriate isolation procedures.
Depending on state informed consent law and precedent, the hospital
may need to inform all patients admitted or in residence at the time of
the immunization program that they may be exposed to smallpox
vaccine virus.
Immunization programs pose difficult human resources issues.
The rnilitary's campaign to immunize troops with anthrax vaccine, a
relatively safe vaccine, resulted in many officers refusing
immunization and, as reported by the GAO, some officers resigned
rather than undergo immunization. 0 9 It should be expected that some
hospital personnel will refuse immunization and others will not be
candidates for immunization. Such personnel cannot care for persons
with vaccine complications and must be excluded from any situation
where they can encounter a person with smallpox in an outbreak.
These issues should be worked out with employee representatives and
unions before immunizations are offered.
VIII. FURLOUGHING EMPLOYEES
Hospitals traditionally had to decide whether to furlough
vaccinated employees until their vaccination healed. Leaving them in
the workplace risked spread to patients and other workers. Even if the
Act protects against patient lawsuits, hospitals need to prevent patient
injuries and the resulting adverse publicity. Furloughing employees is
costly and disruptive. The Act is silent on who should pay the cost of
furloughs. There is an OSHA ruling on hepatitis B immunizations that
indicates that a waiver of liability would be a cost to the employee, and
employees should not bear the costs of immunizations.!10 Analogizing
109. Anthrax Vaccine: GAO's Survey of Guard and Reserve Pilots and
Aircrew, (GAO Rep. GAO-02-445, 2002), available at http://www.gao.gov/
new.items/d02445.pdf and http://biotech.law.Isu.edu/blaw/GAO/anthrax-military.
pdf.
110. Letter from Roger A. Clark, Director, Directorate of Compliance Programs,
Occupational Safety & Health Administration, U.S. Dep't of Labor, to Anne M.
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to smallpox, the Act's requirement that the vaccination be voluntary
seems to require that the employee not bear the cost. Having the
employee bear both the risk of injury and the cost of a furlough seems
to undermine the intent of the Act.
Hospitals are reluctant to remove workers because of the costs of
paying them and hiring others to cover their shifts. If immunized
persons stay in the workplace, they pose a risk to immunosuppressed
patients and immunosuppressed co-workers. Co-workers are covered
by workers compensation insurance, but there are no limits on liability
for injuries to third parties, unless covered by the Act. Arguably, some
state caps on medical malpractice claims would not apply, because this
is not medical malpractice but, rather, a risk arising from an
administrative decision."' Even with the Act's protections, the
conflicting federal recommendations make deciding whether to
furlough employees a difficult question. While the CDC
recommendations allow employees to continue working with patients,
this conflicts with the FDA approved label for DryVax® which states
that "Recently vaccinated healthcare workers should avoid contact with
patients, particularly those with immunodeficiencies, until the scab has
separated from the skin at the vaccination site." '12
This would seem to indicate that vaccinated employees should be
removed from patient care, if not from the workplace. The CDC
recommendations do not require workers to be removed from the
workplace; instead, they recommend that the vaccination sore be
carefully bandaged and that the health care workers wash their hands
properly." 3 However, the CDC recommendation provides no legal
protection, implying that if there is spread, then there was negligent
hand washing or vaccination care. If there is secondary spread to
patients, the hospital will have to explain why it did not follow the
FDA 's warnings. Even if the health care worker and employer are
protected from legal liability by the Act, they will face public relations,
community, and perhaps regulatory pressures if there are patient
injuries.
Preventing spread from vaccinated workers to patients will require
the vaccination of workers in small groups so that newly immunized
persons can be assigned to work that will keep them away from
immunosuppressed patients. This will also mean keeping them from
Sturtz, Assistant General Counsel, VOCA Corp. (July 22, 1993), available at
http://biotech.law.lsu.edu/cases/occmed/07-22-1993.htm.
111. While there are no direct cases on point, this argument would be based on
the assumption that the hospital was not providing medical care when vaccinating
employees, but was engaged in a workplace safety action. If the third parties were
injured, it would be a business negligence case, not a medical malpractice case
because the vaccination of the employee was not part of the patient's medical care.
112. DryVax ® Package Insert, supra note 11.
113. CDC, Guidance II, supra note 9.
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answering emergency calls or other situations where they cannot
control the patients that they treat. The larger the population of
immunosuppressed patients, the greater the risk. Cancer hospitals and
other institutions with large concentrations of immunosuppressed
persons should furlough vaccinated workers.
IX. THE HOMELAND SECURITY ACT PROVISIONS FOR LEGAL
IMMUNITY
The Homeland Security Act" 4 (Act) provides general protections
for persons and institutions assisting the government during a
bioterrorism incident and specific protections for smallpox vaccination
programs. The smallpox provisions are found in section 304 of the
Act: Conduct of Certain Public Health-Related Activities." 5 While
the White House wanted to start civilian vaccinations before the Act
went into effect, there would have been no legal protections for heath
care institutions had they proceeded. Health care institutions were
unwilling to participate until the immunity provisions were in effect.
The Act went into effect on January 24, 2003, and the Secretary of
Health and Human Services (HHS) issued the required Declaration that
smallpox poses a potential public health emergency requiring smallpox
vaccinations as a countermeasure at the same time." 6 This declaration
establishes who will be involved in providing the countermeasures.
The Act only protects persons involved with the smallpox vaccination
program as defined in the Secretary's Declaration." '1 This section also
gives the Secretary broad powers to define more general
countermeasures for bioterrorism threats." 8
The Act uses a strategy for legal immunity that has been used in
other laws, including the immunity provisions for federally qualified
community health centers: 119
114. Homeland Security Act of 2002, Pub. L. No. 107-296, 116 Stat. 2135
(2002), available at http://biotech.law.Isu.edu/blaw/bt/smallpox/hls-final.htm. The
Act changed numerous sections of the U.S. Code. Id. For example, section
214(a)(1)(A) was codified at 6 U.S.C. § 133(a)(1)(A) (2004).
115. Id. § 304, codified at 42 U.S.C. 233 (2004), available at http://biotech.law.
lsu.edu/blaw/bt/smallpox/5710-304.htm.
116. Declaration Regarding Administration of Smallpox Countermeasures, 68
Fed. Reg. 4212 (Jan. 28, 2003), available at http://a257.g.akamaitech.net/
7/257/2422/14mar20010800/edocket. access.gpo.gov/2003/pdf/03-2012.pdf and
http://biotech.law.Isu.edu/blaw/bt/smaflpox/HHSdeclaration1-28-03.pdf [hereinafter
Smallpox Declaration]. This declaration has been extended to January 2005. 69
Fed. Reg. 3920 (Jan. 27, 2004), available at http://a257.g.akamaitech.net/
7/257/2422/14mar20010800/ edocket.access.gpo.gov/2004/pdf/04-1631.pdf.
117. Smallpox Declaration, supra note 116.
118. Id.
119. Motley v. U.S., 295 F.3d 820 (8th Cir. 2002), available at
http://biotech.law.lsu.edu/cases/immunity/motley.htm.
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For purposes of this section, and subject to other provisions
of this subsection, a covered person shall be deemed to be an
employee of the Public Health Service with respect to
liability arising out of administration of a covered
countermeasure against smallpox to an individual during the
effective period of a declaration by the Secretary under
paragraph (2)(A). 12
0
Deeming covered persons to be employees of the Public Health
Service means that any claims for their negligence must be filed
against the Federal government under the Federal Tort Claims Act
(FTCA), 121 subject to its defenses as discussed below. The Federal
Government is substituted for the defendant in such cases, which
provides nearly complete legal protection for the hospital or the
individual who is the real subject of the claim. 122  Under the
Department of Justice's opinion, reflected in the Secretary's letter,
this provision should provide complete immunity for tort claims
against health care workers and their institutions. However, there
are very likely to be courts who will reject this immunity. At this
point, the only way to clarify the immunity provisions will be further
legislation by Congress.
Section 304 continues to define covered persons as:
(B) Covered Person-The term 'covered person', when used
with respect to the administration of a covered
countermeasure, includes any person who is-
(i) a manufacturer or distributor of such countermeasure;
(ii) a health care entity under whose auspices such
countermeasure was administered;
(iii) a qualified person who administered such
countermeasure; or
(iv) an official, agent, or employee of a person described in
clause (i), (ii), or (iii).123
120. Homeland Security Act of 2002, Pub. L. No. 107-296, § 304(p)(1), 116 Stat.
2135 (2002) (codified at 42 U.S.C. § 233(p)(1)), available at
http://biotech.law.lsu.edu/blaw/bt/smallpox/hls-final.htm (amending the Public
Health Service Act, 42 U.S.C. 233, by adding subsection (p)).
121. Federal Tort Claims Act, Pub. L. No. 79-601, 60 Stat. 842 (codified as
amended in scattered sections of 28 U.S.C.). See, LSU Law Center, Medical and
Public Health Law Site, Federal Tort Claims Act, at http://biotech.
law.lsu.edu/cases/immunity/ftca.htm, for cases interpreting the FTCA.
122. 28 U.S.C. 2671-2680 (2004).
123. Homeland Security Act of 2002, Pub. L. No. 107-296, § 304(p)(7)(B), 116
Stat. 2135 (2002) (codified at 42 U.S.C. § 233(p)(7)(B) (2004)), available at
http://biotech.law.lsu.edu/blaw/bt/smallpox/hls-final.htm.
2004]
LOUISIANA LAW REVIEW
Persons who actually perform vaccinations are clearly covered by
clause (iii). The rest of the hospital's employees are covered by
clause (iv). One major problem, however, is that most physicians
who provide care in hospitals are independent contractors. Even in
university teaching hospitals, where everyone appears to work for
the hospital, it is common for the physicians to work for an
independent company that contracts with the hospital. The law in
most states recognizes this independent contractor arrangement and
holds that physicians are not officials, agents, or employees of the
hospital.'24 This is a basic premise of hospital liability law: in most
states, a plaintiff cannot sue the hospital for the malpractice of a
physician on the medical staff because the physician is not an agent
or official of the hospital. Thus there is strong precedent, and even
statutory law, that physicians do not meet the requirements of clause
(iv) to be covered by the provisions of section 304 unless the y are
personally vaccinating others or are employees of the hospital. A
court could rule that a vaccinated physician who spreads the virus
can be sued personally and is not covered by the Act.
On December 9, 2002, the CDC posted a Question and Answer
on the immunity provided by section 304 of the Homeland Security
Act. 126  Contrary to the reading of the Act by most other legal
experts, the CDC has concluded that the Act would not cover most
hospitals:
Q.16. Will hospitals or other institutions who employ
vaccinees but who do not operate as a clinic administering
countermeasures be covered by Section 304 protections?
A.16. Generally, no. Only hospitals and institutions under
whose auspices countermeasures are administered are
covered by Section 304 protections.
27
While the CDC's legal interpretation is not binding on the federal
courts, it is a significant red flag because it must be assumed that the
124. Grewe v. Mt. Clemens Gen. Hosp., 273 N.W.2d 429 (1978) (as expanded
in Chapa v. St. Mary's Hosp. of Saginaw, 480 N.W.2d 590 (1991)). See also
Fiorentino v. Wenger, 227 N.E.2d 296 (N.Y. 1967).
125. Some physicians, such as emergency room physicians, who look like
employees to patients, have been found to be ostensible agents. See, e.g., Torrence
v. Kusminsky, 408 S.E.2d 684 (W.Va. 1991); Jacoves v. United Merchandising
Corp., 11 Cal. Rptr. 2d 468 (Cal. Ct. App. 2d Dist.), review denied (1992); Drennan
v. Community Health Inv. Corp., 905 S.W.2d 811 (Tex. Ct. App.-Amarillo),
rehearing overruled (1995), writ denied (1996); and Burless v. W. Va. University
Hospitals, Inc., 601 S.E.2d 85 (W.Va. 2004).
126. Centers for Disease Control and Prevention, Smallpox Questions and
Answers, Section 304 of the Homeland Security Act (Dec. 9, 2002), available at
http://biotech.law.lsu.edu/blaw/bt/smallpox/section-304-qa.pdf.
127. Id.
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CDC is privy to more information about the legislative intent of the
Act than has been made generally available. It will also be given
deference by any judges who want to limit immunity under the Act.
The CDC is also recommending that the vaccine be administered by
health departments; this would leave most hospitals subject to open-
ended tort liability for all vaccine related claims. The CDC later
issued a revised Q&A 2 8 and a Guidance for the Healthcare
Community Concerning Section 304 of the Homeland Security
Act,'29 which track the Secretary's views.
In addition, a group of Democratic senators filed Senate Bill 6130
in the 108th Congress which claimed, as a sense of Congress, that
the Homeland Security Act only grants immunity to hospitals that
have their own staff administer the vaccine and that the vaccinated
health care worker him/herself is not given immunity by the Act if
he/she infects another person with vaccinia.13' Such a reading of the
original clause (iv), the text in effect at the time of the vaccination
campaign, is very strained--except for the independent contractor
physicians on the medical staff, other health care workers in a
hospital who are vaccinated should be agents or employees, and the
hospital should be covered if it supports the vaccinations. It is
unclear whether this "sense of the Congress" provision really
reflects the legislative history of the Act or whether it was an
128. Centers for Disease Control and Prevention, Smallpox Questions and
Answers (Revised), Section 304 of the Homeland Security Act (Jan. 17, 2003),
available athttp://biotech.law.lsu.edu/blaw/bt/smallpox/section-304-qa-revised.pdf.
See also, Centers for Disease Control and Prevention, Questions and Answers:
Smallpox Vaccination Program Implementation: Liability Issues, at
http://www.bt.cdc.gov/agent/smallpox/vaccination/vaccination-program-
qa.asp?type=cat&cat=Smallpox+Program+Implementation&subCat I =Liability+
Issues.
129. Centers for Disease Control and Prevention, Guidance for the Healthcare
Community Concerning Section 304 of the Homeland Security Act (Jan. 17,2003),
available at http://www.bt.cdc.gov/agent/smallpox/vaccination/pdf/healthcare-304-
guidance.pdf http://www.bt.cdc.gov/agent/smallpox/vaccination/healthcare-304-
guidance.asp, and http://biotech.law.lsu.edu/blaw/bt/smallpox/healthcare-304-
guidance.pdf.
130. S. 6, 108'" Cong. (2003), available at http://biotech.law.lsu.edu/
blaw/bt/smallpox/2003s6VII.htm. As of mid-August, 2004, the bill was still
waiting action in the Senate's Judiciary Committee.
131. Id. § 7001, available at http://biotech.law.lsu.edu/blaw/bt/
smallpox/2003s6VII.htm.
"The Homeland Security Act of 2002 failed to protect from liability a
vaccinated person who transmits vaccinia accidentally. This section
should be amended to protect these people from liability. The section
also failed to protect hospitals that did not administer the vaccine, but
employ vaccinated health workers. The section should be amended to
clarify which hospitals are covered." Id. § 7001(7).
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attempt to undermine the immunity provisions to enable tort actions
to be filed against hospitals who participate in the smallpox
immunization program.
The Secretary of HHS has released a letter that contradicts the
reading of the bill by the CDC and the Senators who filed it.' 3 He
wrote:
You asked whether liability protection is available under the
following scenario:
Healthcare worker from Hospital A is vaccinated at
Hospital B and then sheds vaccinia to a patient at
Hospital A while working within the scope of
employment.
It is our intention to word the Section 304 Declaration to
include the Secretary's determination that hospitals that
designate employees to receive smallpox countermeasures
under the state's smallpox vaccination plan are participants in
the program and thus are healthcare entities under whose
auspices the countermeasure is administered. After
consulting with the U.S. Department of Justice, we believe
that under this scenario Hospital A would be deemed a
covered person under the Act. 133
The Declaration by the Secretary of HHS attempts to deal with the
coverage of the Act in two ways. 134 First, it broadens the definition
of a covered countermeasure:
Administration of a countermeasure such as smallpox vaccine
is necessarily more involved than the act of placing a drop of
vaccine on a two-pronged needle and inoculating a person's
arm. Determining who is contraindicated; monitoring,
management, and care of the countermeasure site; evaluation
of countermeasure "takes;" and contact transmission of
vaccinia, among other things, all arise out of and are directly
related to and part of the administration of the
countermeasure. All such acts also potentially give rise to
legal liability that, without sufficient protections, may
significantly discourage participation in the smallpox
vaccination program. 
 to
132. Letter from Tommy G. Thompson, Secretary, U.S. Department of Health
and Human Services, to Dick Davidson, President, American Hospital Association
(January 9, 1993), available at http://biotech.law.lsu.edu/blaw/bt/smallpox/hhsl-
9letter.pdf.
133. Id.
134. Smallpox Declaration, supra note 116.
135. Id.
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This provision of the declaration must be read in conjunction with the
language of the enabling statute giving the Secretary the authority to
issue this part of the declaration:
(ii) Covered Countermeasure-The Secretary shall specify in
such declaration the substance or substances that shall be
considered covered countermeasures (as defined in paragraph
(8)(A)) for purposes of administration to individuals during
the effective period of the declaration. 13 6
The referenced paragraph (incorrectly referenced in the statute as
(8)(A), which does not exist, rather than (7)(A)), uses a much
narrower definition of covered measure:
(A) Covered Countermeasure-The term 'covered
countermeasure', or 'covered countermeasure against
smallpox', means a substance that is-
(I) used to prevent or treat smallpox (including the vaccinia
or another vaccine); or
(II) vaccinia immune globulin used to control or treat the
adverse effects of vaccinia inoculation; and
(ii) specified in a declaration under paragraph (2). ' 7
When these provisions are read together, the Homeland Security
Act seems to limit covered countermeasures to the vaccine, vaccine
immunoglobulin, and other substances used to prevent or treat
smallpox. Covered countermeasures seems to refer only to
substances (drugs and vaccines), not to the service of administering
them. Referring to the definition of a person who gets immunity,
there is a service-based component: "a qualified person who
administered such countermeasure." '138 The Secretary's definition of
administer includes every conceivable health care service related to
a vaccinated person. There are problems with this broad definition.
There are three plain language meanings for "administer:"
1. To manage or conduct, as public affairs; to direct or
superintend the execution, application, or conduct of; as, to
administer the government or the state.
2. To dispense; to serve out; to supply; execute; as, to
administer relief, to administer the sacrament.
[Let zephyrs] administer their tepid, genial airs.-Philips.
Justice was administered with an exactness and purity not
before known.-Macaulay.
136. 42 U.S.C. § 233(p)(2)(A)(ii) (2004).
137. Id. § 233(p)(7)(A).
138. Id. § 233(p)(1)(B)(iii).
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3. To apply, as medicine or a remedy; to give, as a dose or
something beneficial or suitable. Extended to a blow, a
reproof, etc.
A noxious drug had been administered to him.-Macaulay. 3 9
While the first definition would seem to work for the Secretary, the
Act does not refer to the administration of the vaccination program
but the administration of a countermeasure, i.e., a drug or vaccine.
This fits definition three much more closely-to give or apply a
medicine. In no other context would we equate (a) administering a
drug to treat or to prevent a disease with (b) the entire bundle of
services involved with managing the disease. For example, would a
law giving immunity for administering insulin be taken to protect
every aspect of caring for a diabetic patient? The Secretary's reading
of the Act might be found permissible, but could as easily be rejected.
The Secretary then tries to modify the statutory language itself:
"Official, agent, or employee" as used in Section
224(p)(7)(B)(iv) of the PHS Act and with respect to health
care entities under whose auspices covered countermeasures
are administered, includes health care workers who share any
employment or other staffing relationship with the health care
entity. '
"Staffing relationship" is not defined in the statute or in health care
law more generally. If it means "agent" or "official," it is circular
and does nothing to resolve the problem of independent contractor
physicians. If it is an attempt to include independent contractor
physicians by including medical staff members, then a court would
have to read it against the plain language of the statute, which limits
coverage to officials, agents, and employees. This might be a
permissible broadening in states that do not recognize the
independence of medical staff members. In most states, however, a
court will read this provision in the light of specific state case law
that says that medical staff members are not agents or officials or
employees of hospitals. Those courts are unlikely to find that the
secretary has the power to change the legally established standards
for agent, official, or employee. This construction problem will be
exacerbated by the policy arguments of the plaintiffs. They will
argue that the Act's plain language says that it protects vaccine
manufacturers, persons vaccinating other persons, persons treating
vaccine complications, and the hospitals they work for. Plaintiffs
will claim the language was never meant to cover the careless spread
139. Webster's Revised Unabridged Dictionary (1998).
140. Smallpox Declaration, supra note 116.
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of vaccinia to innocent third parties, and following the Secretary's
interpretation would deny compensation to deserving persons.
The simplest way for hospitals to manage the problem of
independent contractor risk is to have them sign agency agreements
that bring them under the clear language of the Act. Hospitals and
health departments should sign written agreements with all
independent contractor physicians they will be working with or who
practice in their facilities. These agreements should include
provisions:
1) that the physicians will be participating in the entity's
administration of countermeasures as defined by Section 304
of the Homeland Security Act and the Declaration by the
Secretary of HHS as authorized under the Homeland Security
Act;
2) that for the purposes of Section 304 immunity the
physicians are acting as agents of the hospital or health
department and thus are covered by Section 304 immunity
and that any claims against the physicians must be brought
against the Secretary of HHS as provided in the Homeland
Security Act; and
3) that this agency agreement for the purposes of participating
in the smallpox vaccination plan does not make these
physicians agents of the hospital or health department for any
other purpose.
These agreements should be signed before the hospital participates
in the plan. Ideally, the agreement will be between the health
department and the contractors. This will prevent the agreements
from being used as evidence of a general agency relationship in
vicarious liability cases alleging that a negligent physician was an
agent of the hospital.
X. NON-PARTICIPATING HOSPITALS
Many hospitals chose to defer their participation in the smallpox
vaccination program. These decisions were based on many factors,
including the continuing ambiguity of the legal protections provided
by section 304, the problem of compensating injured workers and
others, and fundamental questions about the epidemiologic soundness
of the program. Nevertheless, these hospitals had to develop a policy
to deal with health care workers who were vaccinated during military
reserve duty or who want to be vaccinated outside the hospital's own
program.
Workers vaccinated by the military are covered by the military's
compensation program rather than the hospital's worker's
2004]
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compensation insurance. This program probably does not provide
protection for the hospital if a patient or a co-worker contracts
vaccinia from a vaccinated reservist who has returned to the hospital
before the vaccine sore has healed.'4' Ideally, such vaccinated
persons would be removed from patient care until they are no longer
infectious, but many hospitals cannot afford the financial or staffing
problems such removal would create.
Employees of a non-participating hospital who seek vaccination
on their own pose more difficult issues. It is arguable that if these
persons suffer a vaccine-related injury, they will not be covered by
the hospital's worker's compensation program because they were
vaccinated outside of work and there is no benefit to the employer.
A non-participating hospital could establish a policy that any
employee who undergoes vaccination elsewhere must take personal
time off from work until the vaccine sore heals. Such a decision
could have adverse consequences for a hospital's reputation; for
instance, the hospital might be seen as unpatriotic. It is possible in
some states that the person could sue under state law to be paid for
the lost time, but the success of such an action would depend on
specific state provisions that are beyond the scope of this article.
If the hospital wants to prevent vaccinated workers from returning
until they are non-infectious, it should adopt a clearly argued policy
statement about why the institution is not participating in the program
and why vaccinated employees pose a threat to patients and other
workers. Such a policy is apt to be critical in defending against
claims for lost wages by furloughed employees.
If the hospital wants to allow these vaccinated workers to return
to the workplace, it should enter into an agreement with the local or
state health department. This agreement should state that while the
hospital is not recommending that its employees be vaccinated at this
time, it is participating in the smallpox immunization plan by
allowing employees who have been vaccinated away from work to
continue working in the facility. The purpose of this agreement is to
141. For example, the Army's smallpox web site contains only the following
consideration of liability to third parties:
Civilian Healthcare Responsibilities
1) 1 just got vaccinated against smallpox and I "moon-light" at a civilian
hospital downtown. Should I tell the civilian hospital?
Yes. You should inform the other hospital of your recent vaccination and
tell them about your bandaging procedures and infection-control practices.
You should then abide by any further instructions from the civilian
hospital.
Dep't of Defense Smallpox Vaccination Program, Resource Center: Q&A: Civilian
Healthcare Responsibilities, at http://www.smallpox.mil/resource/
qaAll.asp?clD=140.
[Vol. 64
EDWARD P. RICHARDS
deflect arguments that hospitals that do not recommend vaccinations
are not covered by section 304.
XI. IS WORKER'S COMP COVERED BY THE ACT?
The Act's immunity applies to "liability arising out of
administration of a covered countermeasure against smallpox to an
individual"' 4 2 Such immunity clearly applies against a person
suffering a vaccine complication who wants to sue for medical
malpractice or products liability related to bad vaccine or negligent
administration. It probably does not apply to worker's compensation
claims by hospital employees injured by vaccination. Worker's
compensation is a not a liability claim, but a statutory trading of
liability claims for an insurance system that does not require a
showing of fault for compensation. A court construing this section
would also have strong policy grounds for finding that it does not
apply to worker's compensation claims: if this provision blocks such
claims, then an injured employee would receive no compensation at
all. Thus, we predict that the court would likely find a manifest
injustice if the employee is injured in the course and scope of his/her
job, yet has no avenue for compensation for medical costs and lost
wages.
XII. PROTECTIONS FOR SECONDARY SPREAD
Other provisions of the Act create a rebuttable presumption that
secondary spread of vaccinia is due to the vaccination of a person
covered by the Act and therefore is a case covered by the Act.14 3
Thus, patients or family members who suffer vaccine-related injuries
from contact with a vaccinated person would have to sue for
compensation under the provisions of the FTCA. To rebut this
presumption, the plaintiff would have to show that he/she was
exposed to vaccinia through an unauthorized source of vaccine.
XIII. BLACK-MARKET VACCINE
Section 304 does not apply to claims for vaccine that is
administered outside the federally-sponsored program, i.e., black-
market vaccine, which is the only way someone could be exposed to
vaccinia that did not originate with the federal immunization
program. Given public demand for vaccine, some almost certainly
will be diverted and used for family members or sold on the black
142. 42 U.S.C. § 23 3(p)(1) (2004).
143. Id. § 233(p)(2)(c).
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market. Furthermore, it is relatively easy to use traditional
vaccination techniques described in old texts to extract vaccinia-
laden tissue from an active vaccine sore and use that tissue to
immunize others. These activities are not covered by the Act and
would be subject to existing state and federal tort and criminal laws.
XIV. RECOVERY UNDER THE FTCA
The FTCA waives the sovereign immunity of the United States
and allows certain tort claims to be brought against the United States
and its employees.'" The FrCA applies to negligent torts, and the
standard for proving negligence is drawn from the tort law of the
state where the incident happened. The FTCA does not allow
products liability or strict liability claims. It is an administrative
compensation system and requires that a claim be filed with the
government before the plaintiff can go to court.'45 If the government
does not act on this claim or does not make a satisfactory offer of
settlement, the plaintiff may then go to court."
The United States may use the tort defenses allowed by state law.
The United States may also rely on a statutory defense provided in
the FTCA, the discretionary authority provision:
based upon an act or omission of an employee of the
Government, exercising due care, in the execution of a statute
or regulation, whether or not such statute or regulation be
valid, or based upon the exercise or performance or the
failure to exercise or perform a discretionary function or duty
on the part of a federal agency or an employee of the
144. The FTCA does not apply to active duty military personnel, whose only
remedies are through military compensation systems. Feres v. U.S., 340 U.S. 135,
71 S. Ct. 153, (1950), available at http://biotech.law.lsu.edu/cases/
immunity/feres.v us.htm.
145. Overview-Section304: Liability Protection for Injury Claims Arising out
of Administration of Smallpox Countermeasures (January 14, 2003), available at
http://www.bt.cdc.gov/agent/smallpox/vaccination/imagesliability-protection-
flowchart.gif, and http://biotech.law.lsu.edu/blaw/bt/smallpoxliability-protection-
flowchart.gif (CDC Claims Flowchart). The chart, captioned "Flowchart: Liability
Protection for Injury Claims Arising out of Smallpox Countermeasures," is included
on the CDC web site in a series of questions and answers, at:
http://www.bt.cdc.gov/agent/smallpox/vaccination/vaccination-program-
qa.asp?type=cat&cat=Smallpox+Program+Implementation&subCat 1 =Liability+
Issues. See also Motley v. U.S., 295 F.3d 820 (8th Cir. 2002), available at
http://biotech.law.lsu.edu/cases/immunity/motley.htm.
146. More information on this claims process see, LSU Law Center, Medical
and Public Health Law Site, Federal Tort Claims Act: Brief-Medical Malpractice
Claims Against Public Health Service and Federally Funded Community Health
Center Physicians, at http://biotech.law.lsu.edu/cases/immunity/
malpracticeftca.htm.
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Government, whether or not the discretion involved be
abused. "'
Varig Airlines 48 was a tort claim which asserted that the FAA was
negligent because it spot-checked a sample of airplanes for a
particular problem rather than checking them all. 149 The United
States Supreme Court ruled that since the statute and regulations were
silent on the proper way to conduct inspections, it was within the
agency's discretion to select the inspection technique and that the
agency could not be sued for this decision.150 In Berkovitz by
Berkovitz v. United States,'5' the FDA was sued for not requiring full
testing information for all batches of polio vaccine.'52 In that case,
the United States Supreme Court found that the agency regulations
mandated that the FDA have the full information before approving
the vaccine, and thus that the agency had no discretion to approve
vaccine without the complete information. 15 3 These two cases set out
the key parameters for the discretionary authority defense: the agency
must follow statutes and regulations, but if these allow a policy
decision to be made by the agency, the agency cannot be sued on the
plaintiff s allegation that this decision was negligent.
XV. CONTRAST WITH THE SWINE FLU LEGISLATION
Until the 1970s, there was no expectation of compensation if
someone was injured by a vaccine. There had been some tort claims
based on impure vaccines, but these were exceptional.' 54 Most
people obtained vaccinations for themselves and their children
because they were frightened of contracting the diseases at which the
vaccines were directed. While there have always been persons who
opposed vaccination, they were a tiny minority, and legal policy
reflected the majority view that vaccine injuries were the necessary
cost of reducing one's risk of contracting a deadly disease. As these
diseases were eradicated or reduced to sporadic outbreaks, people
147. 28 U.S.C. § 2680(a) (2004).
148. United States v. S.A. Empresa de Viacai Aerea Rio Grandense (Varig
Airlines), 467 U.S. 797, 104 S. Ct. 2755 (1984), available at http://biotech.law.
lsu.edu/cases/immunity/varig.htm.
149. Id.
150. Id.
151. Berkovitz by Berkovitz v. U.S., 486 U.S. 531, 108 S. Ct. 1954 (1988),
available at http://biotech.law.lsu.edu/cases/immunity/Berkovitz-
byBerkovitz.htm.
152. Id.
153. Id.
154. For a compilation of vaccine liability cases see LSU Law Center, Medical
and Public Health Law Site, Vaccine Law, at http://biotech.law.lsu.
edu/cases/vaccines/index.htm.
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became less tolerant of vaccine injuries, which led to the
discontinuation of smallpox vaccinations in the early 1970s. As these
diseases faded from memory, tort lawyers and vaccine opponents
convinced people that vaccines were dangerous, fueling resistance to
vaccinations and a tsunami of litigation.
The breakdown of community support for vaccinations and the
resulting legal repercussions were exacerbated by the swine flu
immunization program in 1976. Swine flu, so named because it was
first detected in pigs, worried flu specialists at the CDC because they
believed that it resembled the virus responsible for the 1918-1919
Spanish flu pandemic. Spanish flu had swept the world, killing
hundreds of thousands in the United States and tens of millions
worldwide. 56  The CDC pushed for an emergency vaccination
program for swine flu. Given the time frame for vaccine production
and testing, and given the legal climate in 1976, the vaccine
manufacturers refused to produce vaccine unless they were given
complete legal protection. Congress enacted legislation protecting
the manufacturers by shifting the legal liability to the United
States.'57 Since the backers of the immunization program did not
foresee any significant complications, this was a generous fund
which made it easy to recover against the government.'
The Homeland Security Act provisions for smallpox vaccine
injury compensation also treat all claims for liability as claims
against the United States. 5 9 The plaintiff files a claim as if he is
suing a United States Public Health Service employee. This makes
155. See Fenner, supra note 12, at 309-11, see, e.g., Gottsdanker v. Cutter
Laboratories, 6 Cal. Rptr. 320 (Cal. App. 1 st Dist. 1960); Reyes v. Wyeth Lab., 498
F.2d 1264 (5th Cir. 1974).
156. Public Broadcasting Service, A Science Odyssey: People and Discoveries:
Worldwide Flu Pandemic Strikes, 1918-1919, at http://www.pbs.org/wgbh/a
so/databank/entries/dml8fl.html (last accessed Oct. 6, 2004) [hereinafter PBS,
Worldwide Flu]. The 1919 outbreak killed more civilians in peacetime than the
contending militaries lost in combat in World War I. World War I military
casualties amounted to 8.5 million killed and about 21 million wounded. Public
Broadcasting Service, World War I Casualty and Death Tables, at
http://www.pbs.org/greatwar/resources/casdeath-pop.htm (last accessed Oct. 6,
2004). By contrast, the flue epidemic killed, worldwide, about 21 million people
by late 1919. PBS, Worldwide Flu, supra this note.
157. National Swine Flu Immunization Program of 1976 (The Swine Flu Act),
Pub. L. No. 94-380, 90 Stat. 1113 (1976) (codified at 42 U.S.C. § 247b(j)-(l)
(1976)) (repealed by Pub. L. No. 95-626, 92 Stat. 3574 (1978)).
158. See In re Swine Flu Immunization Products Liability Litigation, 533 F.
Supp. 703,719 (D. Utah 1982), aff'd by Unthank v. U.S., 732 F.2d 1517 ( 1 0th Cir.
1984).
159. Homeland Security Act of 2002, Pub. L. No. 107-296, 116 Stat. 2135
(2002) (codified at 42 U.S.C.), available at http://biotech.law.lsu.edu/
blaw/bt/smallpox/hlsfinal.htm.
886 [Vol. 64
EDWARD P. RICHARDS
the FTCA the measure of damages and liability. This approach is
superficially similar to the protections given the manufacturers of
the swine flu vaccine. It is possible, but unknown, that Congress
intended to give the same protections to persons injured by smallpox
vaccine that it gave to persons injured by swine flu vaccine.
However, despite the superficial resemblance of section 304 to the
swine flu legislation, the language in the swine flu immunity statute
was very different. The Swine Flu Act provides:
[T]he liability of the United States arising out of the act or
omission of a program participant may be based on any
theory of liability that would govern an action against such
program participant under the law of the place where the act
or omission occurred, including negligence, strict liability in
tort and breach of warranty. 160
By contrast, the FTCA does not recognize strict liability claims and
probably does not recognize breach of warranty claims. These
theories were used in most of the swine flu cases but would not be
available to persons injured by smallpox vaccine. More importantly,
the Unthank court found that the legislative history of the swine flu
legislation indicated that this language was intended to set up a no-
fault compensation scheme:
The trial court was particularly impressed, as we are, with
the explicit statements of Senator Harrison A. Williams, Jr.
of New Jersey in discussing the reasons for enacting this bill
establishing liability against the federal government. He said:
This is pioneering in the sense, it has never been done
before, but it is in response to an emergency. That is
the way the liability fixes upon the government,
through the total class act, for any misfortune which
would follow, as defined, the administration of the
inoculation and vaccine ... 192 [sic] Cong.Rec. 26632
(August 10, 1976).
The trial court was also impressed, as we are, with the
statement of Congressman Paul G. Rogers of Florida:
[W]e have asked the drug companies to produce this
vaccine. We have told them how to do it. We have told
160. National Swine Flu Immunization Program of 1976 (The Swine Flu Act),
Pub. L. No. 94-380, § 2, 90 Stat. 1113 (1976) (codified at 42 U.S.C. § 247b(k)(2)
(A)(i) (1976)) (repealed by Pub. L. No. 95-626, 92 Stat. 3574 (1978)).
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them the dosage we want, what strength. We gave
them the specifications because we are the only buyers,
the Government of the United States. This is not the
usual process of going out and selling. But if someone
is hurt, we think people ought to have a remedy. [122
Cong.Rec. at] p. 26796.161
Since the courts that considered the claims for injuries caused by
swine flu vaccine believed that Congress intended the unusual
language in the swine flu immunity law to create a no-fault
compensation system, they awarded compensation to all persons who
could show that their injuries were caused by the vaccine. Most of
these persons claimed to have Guillain-Barr6 syndrome (GBS). GBS
is a progressive paralysis that affects the legs first, and can become
fatal if it progresses to the point where it affects the patient's
breathing. 62 In most cases it resolves after a few weeks with no long-
term problems. 63 It is diagnosed based on physical examination and
has no definitive laboratory findings."6
Once physicians were notified that there might be a link between the
swine flu vaccine and GBS, they were more likely to diagnose non-
specific neurological disease such as GBS. More troubling, lawyers
who represent injured persons, especially those injured in the
workplace and covered by various compensation statutes, work with
networks of physicians who can be relied on to provide diagnoses and
treatments that support the worker's compensation claims. When
patients in these cases were sent to physicians by lawyers, it can be
assumed that, as in other compensation cases, these physicians were
more likely to make a diagnosis of GBS.
This bias in diagnosis had two effects. First, it resulted in a flood of
legal claims. Second, and more troubling, it likely distorted the
conclusions that could be drawn about the relation between swine flu
and GBS. GBS is rare, and the association with the swine flu vaccine
was weak at best. Shifting even a few cases to a diagnosis of GBS
would make a huge difference in the statistical association between the
vaccine and GBS. Subsequent analysis indicates that there was
probably no link between the swine flu vaccine and GBS.'65 This
161. Unthank v. U.S., 732 F.2d 1517, 1520 (10' Cir. 1984), available at
http://biotech.law.lsu.edu/cases/vaccines/Unthank.htm (emphasis added by the
court).
162. National Institute of Neurological Disorders and Stroke, Guillain-Barr
Syndrome Fact Sheet, at http://www.ninds.nih.gov/health-andmedical/pubs/
guillain-barre.htm.
163. Id.
164. Id.
165. D.A. Freedman & Philip B. Stark, The Swine Flu Vaccine and Guillain-
Barri Syndrome: A Case Study in Relative Risk and Specific Causation, 23
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established the pattern for subsequent vaccine litigation wherein
attorneys took the lead in finding experts to identify new injuries,
leaving the epidemiologists to try to convince the public that the
vaccines are really safe.
The flood of litigation and the interplay between the legal cases
and the issue of scientific causation became characteristic of vaccine
injury litigation. In the early 1980s, vaccine litigation over baseless
claims threatened to drive all the manufacturers out of the business
of making vaccines. 166 As vaccine injury litigation began to make it
impossible to find companies willing to make vaccine, Congress
passed the National Childhood Vaccine Injury Act in 1986.167 This
Act provided compensation for children allegedly injured by vaccines
and provided some immunity for vaccine manufacturers.' The Act
was good politics, if not good policy, and created the expectation that
the federal government should provide compensation if it wants
people immunized for communicable diseases. This expectation of
compensation was heightened for the smallpox vaccine, which is
much more dangerous than any other approved vaccine. Most health
care providers have balked at being vaccinated because of their own
fear of injury and because patients inadvertently injured through
secondary transmission have no avenue for compensation under the
Homeland Security Act, and hence might bring suit against the
provider from whom the disease was contracted. At the same time,
Congress was concerned about a law that would provide large
financial incentives to persons injured by the vaccine and thus
encourage unjustified claims.
XVI. COMPENSATION UNDER THE HOMELAND SECURITY ACT
In contrast with the swine flu law, the Act includes no extensions
of liability or modification of the terms of the FTCA. There is also
no congressional history to indicate that despite the absence of such
language, the House intended that every injured person be
compensated. Under the unmodified language of the FTCA, it is
very hard to obtain compensation from the government for risks to
which the government knew it was exposing people. Since most of
Evaluation Review 619 (1999).
166. Office of Technology Assessment, Compensation for Vaccine-Related
Injuries (1980), available at http://www.wws.princeton.edu/cgi-bin/byteserv.prl/
-ota/disk3/1980/8005/8005.PDF; Mary Beth Neraas, The National Childhood
Vaccine Injury Act of 1986: A Solution to the Vaccine Liability Crisis?, 63 Wash.
L. Rev. 149 (1988).
167. National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660 §§
301-323, 100 Stat. 3755 (1986) (codified in scattered sections of 42 U.S.C.).
168. 42 U.S.C. § 300aa-I 1(2004).
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the risks of the smallpox vaccine are very well known, by choosing
to immunize a given class of persons, the government is making a
discretionary decision to expose that class of persons to the risks.
This decision cannot be attacked under the FTCA, so it is a defense
against claims for smallpox vaccine injures. The best analogy is the
cases in which persons downwind from nuclear test sites sued the
government for injuries allegedly caused by exposure to fallout. 169
The district court, in a 255-page opinion, found that these persons
had suffered injuries and that the government was liable for exposing
them to fallout.17° In little more than one page, the appeals court held
that since the government had decided to expose the plaintiffs to
fallout, knowing the risks, it was not liable under the FTCA. 17 ' The
court found that while there was statutory language urging the agency
to balance the risk of harm to the population against the need for
testing atomic bombs, this did not prohibit the agency from deciding
that testing was more important than protecting the population from
fallout. 72
In its plain language, without contrary legislative history, the Act
appears to require that in order to recover under the FTCA, persons
injured by smallpox vaccine must prove that the government or
persons acting on its behalf were negligent in administering the
vaccine, 173 simply proving that they were injured by the vaccine
would not be enough. There are three areas where negligence is most
likely to be alleged: in screening persons for contraindications, in
preventing spread to third parties, and informing persons of the risks
of the vaccine. If the government is careful to document its decisions
in these areas and to explain why these decisions reflect its
determination of public policy, it can probably escape liability for all
injuries that it anticipates and addresses in a policy statement. For
example, while it is clear that every person being immunized should
undergo clinical testing for immune status (a complete blood count
and an HIV test would be a minimum), if the government says that
such testing would interfere with the protection of the public, and that
it was aware that failing to test would injure some persons, then it
would have no liability under the FTCA.
169. Allen v. U.S., 588 F. Supp. 247 (D.C. Utah 1984).
170. Id.
171. Allen v. U.S., 816 F.2d 1417 (10th Cir. 1987), available at
http://biotech.law.Isu.edu/cases/immunity/abomb03.htm.
172. Id.
173. The Homeland Security Act is silent on the specific standard of proof, but
it provides that these claims be brought as if they were claims against the Public
Health Service. Claims against the Public Health Service are governed by the
Federal Tort Claims Act. See Berkovitz by Berkovitz v. U.S., 486 U.S. 531, 108
S. Ct. 1954 (1988); Prescott v. U.S., 973 F.2d 696 (9th Cir. 1992); U.S. v. St. Louis
University, 336 F.3d 294 (4th Cir. 2003).
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The Act provides useful, but incomplete, protection for hospitals
whose personnel are immunized against smallpox. It is the authors'
opinion that the statute leaves the hospital liable for worker's
compensation costs for injured employees. It does relieve the
hospital of liability for secondary spread, which poses the greatest
legal risk. It does not, however, make the government liable for such
spread. Thus patients and family members injured by the vaccine
will not have any recourse and will receive no compensation, even
for permanent disability or death. In the worst-case scenario, their
private insurance carriers will deny coverage because the injures
were related to the preparation for an act of terrorism or war, as
specified in the required declaration by the Secretary.
The care of these injured persons would need to take place
somewhere. Would hospitals refuse to care for their own patients or
their workers' family members who are injured by the hospital's
vaccination plan? Would state and local governments be prepared to
bear the burden of caring for these people? Hospitals and health care
unions have made it clear from the first discussions of a smallpox
vaccination plan for health care workers that compensation for
injured workers is a necessary part of any plan.'74
XVII. THE ROLE OF THE LOCAL PUBLIC HEALTH OFFICIALS
The smallpox vaccination plan was set up to be carried out through
local public health agencies (LPHAs). This is consistent with the
traditional role of the CDC, the implementation agency for the plan.
Historically, the CDC has acted as an advisory agency to state and
local health departments. With the exception of the inspection of
cruise ships,'75 the CDC is not an enforcement agency and does not
174. Letter from Herb Kuhn, Corporate V. Pres., Premier Advocacy [of Premier
Health Plan] and Michael Rodgers, V. Pres., Public Pol'y and Advocacy, Catholic
Health Assoc. of the U.S., to Tommy G. Thompson, Secretary, U.S. Dep't of Health
and Human Services (October 28, 2002), available at http://biotech.law.lsu.edu/
blaw/bt/smallpox/smallpox-ltr-1002.pdf. (Note that their letter was written almost
two months before President Bush made his program announcement on December 13,
2002. See supra note 2.); Press Release, Texas Nurses Association, Clair Jordan,
MSN, RN, Executive Director, Texas Nurses Association Urges Caution For Texas
Nurses Volunteering For Smallpox Vaccine (January 31, 2003), available at
http://biotech.law.lsu.edu/blaw/bt/smallpox/tna.pdf; Press Release, Service Employees
International Union, Nation's Largest Health Care Union Warns That, Without Better
Safeguards, Plan Itself Poses Public Health Risks (December 3, 2003), available at
http://biotech.law.lsu.edu/blaw/bt/smallpox/SEIU-smallpox-.pdf.
175. The Vessel Sanitation Program (VSP) is described by the CDC as "a
cooperative activity with the cruise ship industry ... in order to minimize the risk
of gastrointestinal diseases." Centers for Disease Control and Prevention, About the
Vessel Sanitation Program, at http://www.cdc.gov/nceh/vsp/desc/aboutvsp.htm
(last accessed Oct. 6, 2004).
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have local offices in the states. In theory, it comes into the states
only at the request of the state for assistance. This role is reflected in
the lack of a national disease reporting system or uniform standards
for disease reporting. Individual states decide which diseases are
reportable, the definition of reportable conditions, who has the duty
to report, and how reporting is enforced. States then transmit
whatever data they choose to the National Center for Health Statistics
of the CDC. The result is a hodge-podge of reporting standards, with
some states not requiring basic reporting data even on major disease
threats such as HIV infection.
This role has changed dramatically, if quietly, as the CDC has
become a conduit for federal public health funds, and as states have
reduced their own support for public health. The CDC is now a
critical source of funds for many public health efforts, and it uses its
spending power to shape state and local public health programs. This
dependence on CDC funding has reduced the independence of state
health departments, especially those that have the least amount of
state funding. They must meet CDC standards and objectives to
obtain the federal money that is critical for their day-to-day
operations. In general, this system improves the standards for local
public health, but it also makes some state and local health
departments less willing to speak up when they believe that a federal
program is not in the best interest of their community or will
cannibalize resources needed for other public health activities.
While the smallpox vaccination plan did include some funding,
many departments feared, quite correctly, that the demands on their
staff and resources would exceed the funding provided for the
program. They were also concerned that they would not have the
resources necessary to properly oversee a large-scale vaccination
program that would primarily be carried out in hospitals. LPHAs
should have been prepared to work with hospitals to train workers
about the risks of smallpox immunization and the management of
immunization complications. LPHAs should have been prepared to
investigate home situations as appropriate to ensure the safety of the
family members and significant others of persons who volunteer for
vaccinations. All screening and immunization should have been
carried out by state or local health department employees, not by
hospital personnel. This approach would have solved many of the
questions about privacy issues raised by screening and about liability
for vaccinations. It would have shifted any liability for negligent
screening or unforeseen reactions to the state. Few health
departments were willing to take on these responsibilities because of
legal and staffing concerns. Since smallpox vaccination was intended
as a public health program, this further undermined the support of the
plan by hospitals and other institutional health care providers.
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XVIII. IS THE SMALLPOX VACCINATION PLAN WORTH THE RISK?
The biggest unknown about the smallpox vaccination plan was the
risk of an outbreak of smallpox versus the risk of the vaccination
plan. Unfortunately, of course, probability information is impossible
to obtain for bioterrorist activities. As discussed previously,
smallpox is more problematic than most possible bioterror agents
because there is no clear evidence that the virus is available to
terrorists. Unlike agents such as anthrax and plague, which are
readily available because they are used by many laboratories and
because they have animal reservoirs, smallpox virus will be available
only if it has been diverted from the Soviet bioweapons program. It
is assumed that this information was kept from the CDC and other
public health experts until the late 1990s because the government did
not think it posed a significant threat. Had there been a decision in
1993 that smallpox posed a threat, work should have begun then on
a safe alternative vaccine.'76
The announcement of the smallpox vaccination plan was not
accompanied by any information about why smallpox now had
176. Many public health experts were recommending the destruction of the
remaining virus stocks as late as 1999, on the assumption that these laboratory
stocks were the only remaining source of the smallpox virus. For a history of this
movement and how destruction of the virus was postponed, see World Health
Organization, Advisory Committee on Variola Virus Research, Report of the Fifth
Meeeting, Geneva, Switzerland (Nov. 4-5 2003), available at http://www.who.int/
csr/resources/publications/WHOCDSCSRGAR_2004_15/en/and http://biotech.
law.lsu.edu/blaw/bt/smallpox/ who/WEBWHOCDSCSRGAR_2004_15.pdf;
World Health Organization, Executive Board, 111 ' Session, Smallpox Eradication:
Destruction of Variola Virus Stocks: Report by the Secretariat, Provisional Agenda
Item 5.3, EB 111/5 (Dec. 23, 2004), available at http://www.who.int/gb/
ebwha/pdffiles/EB11 l/eebl 115.pdf and http://biotech.law.lsu.edu/
blaw/bt/smallpox/who/eeb 1115.pdf; World Health Organization, Executive Board,
109t' Session, Smallpox Eradication: Destruction of Variola Virus Stocks: Report
by the Secretariat, Provisional Agenda Item 3.14, EB 109/17 (Dec. 20, 2001),
available at http://ww.who.int/gb/ebwha/pdffiles/EB 109/eeb10917.pdf and
http://biotech.law.lsu.edu/blaw/bt/smallpox/who/eeb10917.pdf; World Health
Organization, Executive Board, 106' Session, Smallpox Eradication: Destruction
of Variola Virus Stocks: Report by the Secretariat, Provisional Agenda Item 5, EB
106/3 (Apr. 10, 2000), available at http://www.who.int/gb/ebwha/pdf-files/
EB 106/ee3.pdf and http://www.biotech. law.lsu.edu/blaw/bt/smallpox/who/ee3.pdf;
World Health Organization, Fifty-Second World Health Assembly, Smallpox
Eradication: Destruction of Variola Virus Stocks: Report by the Secretariat,
Provisional Agenda Item 13, A52/5 (Apr. 15, 1999), available at
http://www.who.int/gb/ebwha/pdf-files/WHA52/ewd2.pdf and
http://biotech.law.lsu.edu/blaw/bt/smallpox/who/ew5.pdf; World Health
Organization, Smallpox EradicationL Destruction of Variola Virus Stocks, 74
Wkly. Epidenioogical Rec. 188 (1999), available at http://www.who.int/docstore/
wer/pdf/1999/wer7424.pdf and http://biotech.law.lsu.edu/blaw/bt/smallpox/who/
wer7424.pdf.
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become a priority, and in fact, the announcement stated that there
was no new, specific risk. There were heated debates in 1972 about
whether smallpox vaccinations should be stopped, with a significant
faction arguing that ending vaccinations would eventually create an
environment that would support a global pandemic of smallpox.'77
That fear has now come to pass, with the events of 9/11
reopening the debate about the wisdom of continuing a world that
is susceptible to smallpox. ff there is a real risk of smallpox, then
perhaps the question should be whether we resume routine
vaccinations for healthy persons, not whether we will vaccinate a
small group of volunteers. If a safer vaccine is developed, resuming
smallpox vaccinations might make sense. With the current vaccine,
on the other hand, the politics of immunosuppression secondary to
HIV complicates the risk calculus-will it really be possible to
protect immunosuppressed persons from vaccination and secondary
spread while keeping their immune status secret?
The best rationale for the smallpox vaccination plan was to
prepare a cadre of medical care providers and front-line emergency
services providers who could deal with cases of smallpox as part of
community response teams. If a smallpox case was identified,
teams could focus on the patients while other health care workers
were being vaccinated and were vaccinating others. This could
have been accomplished if the plan had been set up to recruit
volunteers with specific skills. Such volunteers would have been
vaccinated by the health department personnel, would have been
kept away from direct patient care until the vaccine sore had healed,
and would have been assured of adequate compensation if they
were injured. This would have solved the worker's compensation
and liability issues for the hospitals, and would have addressed the
volunteers' fears about whether they would be compensated if
injured. By focusing on a team for the community, rather than
requiring each hospital to have its own team, relatively few health
177. The American Journal of Epidemiology published a pair of contrsting
articles contending this precise point. S.L. Katz, The Case for Continuing
"Routine" Childhood Smallpox Vaccination in the United States, 93 Am. J.
Epidemiology 241 (1971); J.M. Neff, The Case for Abolishing Routine Childhood
Smallpox Vaccination in the United States, 93 Am. J. Epidemiology 245 (1971).
Additionally, at least one monograph has been devoted to the issue. James C.
Frauenthal, Smallpox: When Should Routine Vaccination be Discontinued?
(UMAP Exploratory Monograph Series, 1981). Fenner alludes to this debate in
Chapter 30, "Potential Sources for a Return of Smallpox, supra note 12, at 1341.
Also note the reaction of many in the medical community to a smallpox death in an
English laboratory accident in 1978: "[m]edical Health administrators in the
developing countries of Africa, in particular, renewed their calls for the cessation
of laboratory studies of variola virus and the destruction of all stocks of the virus."
Id. at 1097.
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care workers would have been needed, which would have reduced
the cost of carrying out the plan.
Instead, the plan was oriented to individual hospitals, on the
assumption that smallpox patients would be flooding the hospital
emergency rooms and would be treated at every hospital. There were
no distinctions drawn between general acute care hospitals and
specialty hospitals such as cancer treatment centers which do not take
walk-in patients. Vaccinated health care workers would care for
these patients in their hospitals. This plan makes no provision for the
other patients in the hospital. Hospitals have a very limited number
of isolation beds suitable for smallpox, and almost no hospitals have
a safe way to transport patients from the front door into those rooms
without exposing others. If there are more than a small number of
smallpox cases, a hospital will no longer be able to isolate them. At
that point all the other patients and unvaccinated staff would have to
be moved out and the facility converted to a smallpox hospital, or the
smallpox patients would have to be sent away.
Smallpox cases should not be admitted or treated in every hospital
in the community. They should be sent to designated regional
smallpox hospitals. To minimize the risk of secondary spread of
smallpox, a regional smallpox hospital should not house a significant
number of immunosuppressed persons. There should be a plan for
how to evacuate all patients and unimmunized staff to other facilities
should smallpox be identified in the community. Ideally, a regional
hospital should be run by a government entity that is shielded from
lawsuits by sovereign immunity. This would allow compensation
under a tort claims act. These regional hospitals should be federal
hospitals such as Veterans Administration hospitals because the
federal government has the best tort law protection and the best
ability to absorb other costs such as worker's compensation claims.
More importantly, a federal facility will be able to absorb the
tremendous financial risks of treating smallpox cases, including the
potential closing of the facility if decontamination proves
impossible.'78 This is important even if the Homeland Security Act
immunity is in place to prevent tort claims.
The plan also fails to deal with the health care workers who cannot
be immunized. These workers will have to be kept away from any
possible smallpox cases for their own safety and because
unimmunized health care workers are a prime way to spread
178. Using a private facility is very problematic because decontamination will
be very expensive and time consuming, and ultimately the public may be frightened
to return to the facility. It may be more prudent to use a motel or other non-medical
structure, which will be much cheaper and less disruptive to destroy rather than try
to decontaminate.
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smallpox. If the country is in a constant state of readiness for a
smallpox outbreak, does this mean that such workers cannot be in any
jobs where they might encounter an undiagnosed smallpox case? If
there is a case identified in the community, should all unimmunized
workers be sent home? Who will cover their duties? What about
health care workers outside of hospitals? Patients are as likely to go to
private physicians as to hospital-based clinics. How should such
facilities handle potential smallpox cases?
XIX. THE SMALLPOX EMERGENCY PERSONNEL PROTECTION ACT OF
2003
After the smallpox vaccination plan had effectively ended, Congress
heeded the call of hospitals and health Care worker unions and enacted
a compensation act for persons injured by smallpox vaccine. On April
30, 2003, President Bush signed HR 1770, the Smallpox Emergency
Personnel Protection Act of 2003,179 which, among other things,
establishes a smallpox vaccine injury compensation fund. This fund
is intended to encourage smallpox vaccinations by addressing fears that
those vaccinated will not have any insurance coverage if they are
injured by the smallpox vaccine. 80 As discussed infra, the fund
proposed by this bill is very restrictive and may not go far enough to
address the concerns of health care providers and their institutions.
The fund is also limited to pre-outbreak vaccination.18' Once a case of
smallpox has been identified, the compensation system is closed to
persons subsequently vaccinated.
The Act is triggered by the Secretary's Declaration under the
Homeland Security Act. The Act begins with the definition of a
covered person:
179. Smallpox Emergency Personnel Protection Act of 2003, 42 U.S.C. §§
261-269, available at: http://biotech.law.lsu.edu/blaw/bt/smallpox/
Congress/hr1 770-passed.htm.
180. Susan Thaul, Smallpox Vaccine Injury Compensation 2 (Cong. Res. Serv.
Rep. 31-960, 2001), available at http://biotech.law.lsu.edu/blaw/
bt/smallpox/Congress/ RL31960.pdf; Democratic Members of the House Select
Committee on Homeland Security, A Biodefense Failure: The National Smallpox
Vaccination Program One Year Later 13 (Jan. 2004), available at
http://www.house.gov/hsc/democrats/pdf/press/040129_ABiodefenseFailureOne
YearLater.pdf and http://biotech.law.lsu.edu/blaw/bt/smallpox/
Congress/040129_ABiodefenseFailureOneYearLater.pdf.
181. A covered individual is someone "who has volunteered and been selected
to be a member of a smallpox emergency response plan described in subparagraph
(B) prior to the time at which the Secretary publicly announces that an active case
of smallpox has been identified either within or outside the United States." 42
U.S.C. § 239(a)(2)(C) (2004).
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(A) who is a health care worker, law enforcement officer,
firefighter, security personnel, emergency medical personnel,
other public safety personnel, or support personnel for such
occupational specialties;1
2
(B) who is or will be functioning in a role identified in a
State, local, or Department of Health and Human Services
smallpox emergency response plan (as defined in paragraph
(7)) approved by the Secretary 183
(C) who has volunteered and been selected to be a member of
a smallpox emergency response plan described in
subparagraph (B) prior to the time at which the Secretary
publicly announces that an active case of smallpox has been
identified either within or outside of the United States;'84 and
(D) to whom a smallpox vaccine is administered pursuant to
such approved plan during the effective period of the
Declaration (including the portion of such period before the
enactment of this part).'8 5
Sections (A) and (B) raise the questions of just what is an
approved plan and what does identification mean-must each
vaccinated person be identified in the plan, or just the role each will
fill? What does it mean to be an approved plan, and what if the plan
is not approved? These sections also exclude persons who get the
vaccine outside of the official program, perhaps through theft or
unauthorized vaccination by someone with legitimate access to the
vaccine.
Section (C) poses two problems: (1) What does it mean to be a
volunteer? If your employer requires you to participate, does this
exclude you from coverage? Is this meant to exclude from coverage
under the Act situations where worker's compensation is clearly
available? (2) Why does eligibility for compensation under the Act
end when a case of smallpox is identified? It is possible that this
provision derives from an assumption that once there is a case of
smallpox, everyone will want to be vaccinated, so the Act would
become unnecessary as an incentive for vaccination. It could also
result from a recognition that once there are mass immunizations
there will be a large number of casualties, and Congress does not
want the government to be responsible for the costs.
Section (D) makes clear that this is a vaccination injury
compensation act and is not intended to address other claims. The
definition of a covered injury is clear:
182. Id. § 239(a)(2)(A).
183. Id. § 239(a)(2)(B).
184. Id. § 239(a)(2)(C).
185. Id. § 239(a)(2)(D).
2004] 897
LOUISIANA LAW REVIEW
(3) COVERED INJURY-The term 'covered injury' means an
injury, disability, illness, condition, or death (other than a
minor injury such as minor scarring or minor local reaction)
determined, pursuant to the procedures established under
section 262, to have been sustained by an individual as the
direct result of-
(A) administration to the individual of a covered counter-
measure during the effective period of the Declaration; or
(B) accidental vaccinia inoculation of the individual in
circumstances in which-
(i) the vaccinia is contracted during the effective period
of the Declaration or within 30 days after the end of such
period;
(ii) smallpox vaccine has not been administered to the
individual; and
(iii) the individual has been in contact with an individual
who is (or who was accidentally inoculated by) a
covered individual.1 86
An individual is covered by the Act if he/she is an eligible
individual or someone who suffers a covered injury. This would
include patients and family members who contracted secondary
vaccinia from a vaccinated person.
The Act requires the Secretary to promulgate a regulation
specifying what injuries are covered by the Act, and it allows the
Secretary to make individualized decisions about injuries not included
in the regulation:
(1) INJURIES SPECIFIED IN INJURY TABLE-In any case
where an injury or other adverse effect specified in the injury
table established under section 263 as a known effect of a
vaccine manifests in an individual within the time period
specified in such table, such injury or other effect shall be
presumed to have resulted from administration of such
vaccine. '87
(2) OTHER DETERMINATIONS-In making determinations
other than those described in paragraph (1) as to the causation
or severity of an injury, the Secretary shall employ a
preponderance of the evidence standard and take into
consideration all relevant medical and scientific evidence
presented for consideration, and may8 obtain and consider the
views of qualified medical experts.
186. Id. § 239(a)(3)(a).
187. Id. § 239a(c)(1).
188. Id. § 239a(c)(2).
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The Secretary's determination of whether someone is injured and
the compensation to which they are entitled is not reviewable in the
courts:
(2) JUDICIAL AND ADMINISTRATIVE REVIEW-No
court of the United States, or of any State, District, territory
or possession thereof, shall have subject matter jurisdiction to
review, whether by mandamus or otherwise, any action by the
Secretary under this section. No officer or employee of the
United States shall review any action by the Secretary under
this section (unless the President specifically directs
otherwise). 89
The medical benefit is limited to second dollar coverage, paying
only what is left after other insurance plans, including worker's
compensation and state and federal coverage such as Medicare and
Medicaid, have paid.
The lost wages benefit is paid at two thirds of the monthly wage
(plus eight and one-third percent if there are dependents).' 9° There is
a cap on all payments of $50,000 per year, with the aggregate not to
exceed the death benefit described infra.'9' As with the medical
benefit, this is second dollar coverage and payment from any other
sources will be deducted.
The Act provides a death benefit and a benefit for total and
permanent disability equal to the benefits paid under the Public Safety
Officers' Benefits Program, which, according to an announcement by
the Secretary of HHS, are $262,100 at this time. 9 2 It appears that this
benefit is to be added to any other benefits that the individual receives,
except for benefits from the Public Safety Officers' Benefits Program
or other payments, such as lost wages, that were made under the
smallpox compensation program. If there are dependants under the age
of eighteen, there is an alternative calculation that results in a yearly
payout until the youngest dependant is eighteen. This is based on
seventy-five percent of the decedent's income, with a cap of $50,000
a year.'9 3 This alternative payment is reduced by any benefits paid to
the dependants by a third party. 194
189. Id. § 239a(f)(2).
190. Id. § 239d(b).
191. Id. § 239d(c)(3)(A)(i).
192. News Release, Dep't of Health and Human Services, HHS Proposes
Smallpox Vaccination Compensation Plan (Mar. 5, 2003), available at
http://www.hhs.gov/news/press/20O3pres/20O3O305.html.
193. 42 C.F.R. § 102.82(d) (2004).
194. Id.§ 102.82(d)(3)(A).
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The subsequent release of the administrative rules'95 for the
smallpox compensation program did not solve the major problems of
the compensation act: the definitions of covered persons can exclude
some injured persons; the benefits are very limited and most are
subrogated to any other benefits; there are no provisions for
compensation to employers; and the provisions for making claims,
even for immediate medical needs, are complex and time-consuming.
Under every provision, the secretary does not have to pay, and
ultimately there is no judicial review of the secretary's decisions. 19 6
The Smallpox Emergency Personnel Protection Act of 2003'9
represents an attempt to draft a compensation act that will not attract
fraudulent claims while taking the fears of health care workers and
others seriously. How well it succeeds in this goal may be
questioned. For example, it appears to provide inadequate
compensation for serious injuries, especially for better-paid workers.
Smallpox is a deadly threat and smallpox vaccinations may be a
necessary part of domestic policy. So far, the federal funding for
smallpox vaccinations for health care workers is much less than the
total costs for health departments and health care institutions. Should
the vaccinees and their employers also absorb some or all of the costs
of injury, or should these be part of the defense budget? The Act
only goes part of the way towards solving this problem. It will be up
to health care providers and others to decide if this is enough, or if
they want to be fully protected financially, If the Act is coupled with
a better plan for handling a smallpox outbreak and with more
information about the probability of a smallpox outbreak, health care
providers might be more willing to accept the risk of vaccination.
XX. THE POST-OUTBREAK ALTERNATIVE
Unlike most vaccines, the smallpox vaccine is fully effective up
to three days after a person is exposed to the virus, and somewhat
effective for a few days more. 98 This is because the incubation time
195. 68 Fed. Reg. 70,080 (Dec. 16, 2003), available at
http://biotech.law.lsu.edu/blaw/hhs/42-crf-102.pdf; Smallpox Vaccine Injury
Compensation Program: Administrative Implementation; Correction, 69 Fed. Reg.
7376 (Feb. 17, 2004) (technical corrections).
196. 42 C.F.R. 102.92 (2004).
197. Smallpox Emergency Personnel Protection Act of 2003, Pub. L. No. 108-
20, 117 Stat. 638 (2003) (codified at 42 U.S.C. §§ 239-239h (2004)).
198. D.A. Henderson, Smallpox: Clinical and Epidemiologic Features, 5
Emerging Infectious Diseases 537, 537 (1999), available at
http://www.cdc.gov/ncidod/EID/vol5no4/henderson.htm. ("Vaccination before
exposure or within 2 to 3 days after exposure affords almost complete protection
against disease. Vaccination as late as 4-5 days after exposure may protect against
death."). The CDC biographical note on Dr. Henderson describes him as
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for smallpox is much longer than for the vaccinia in the vaccine. The
vaccine sore develops quickly, driving the production of antibodies
that then prevent the smallpox virus from gaining a foothold in the
patient. This provides a window of opportunity to vaccinate persons
after exposure and still stop the development of smallpox in most of
them. Given the uncertain, but low, probability of a smallpox
outbreak in any given city, and at any given hospital, an alternative
to prophylactic vaccination is to wait until there is a case of smallpox
and then be prepared to vaccinate people very quickly.
As was demonstrated in the 1947 New York smallpox vaccination
campaign 99 and others around the world,2° large numbers of people
can be vaccinated in a short period of time. Dealing with health care
providers is the simplest case. Vaccine could be stockpiled locally,
even at the hospital and clinic level. It is stable and easy to store,
but would need to be secured. The technique for performing the
vaccination is very simple, having been designed to be done by
unskilled workers after very limited training. The current
recommendations are focused on a zero risk approach, i.e., elaborate
recordkeeping, detailed informed consent, and extensive safety
precautions to prevent the person performing the vaccination from
being exposed to vaccina. These are appropriate precautions for
prophylactic vaccinations when there have been no reported cases of
smallpox.
The risk calculus shifts dramatically as soon as there are active
cases of smallpox in the community. 212 At that point, the risk of not
a distinguished service professor at the Johns Hopkins university, holding
an appointment in the Department of Epidemiology. Dr. Henderson
directed the World Health Organization's global smallpox eradication
campaign (1966-1977) and helped initiate WHO's global program of
immunization in 1974. He also served as deputy assistant secretary and
senior science advisor in the Department of Health and Human Services.
Id. (Dr. Henderson is also one of the five co-authors of the definitive work on
smallpox. See Fenner, supra note 12.).
Additionally, recent research has found that vaccination with 19 year old
DryVax® (manufactured 1982; injected 2001) achieved highly effective reactions
(97% success rate) even when diluted to 10% of the normal strength. Sharon E.
Fry, et. al, Dose-Related Effects of Smallpox Vaccine, 346 N.Eng. J. Med. 1275
(2002), available at http://content.nejm.org/cgi/content/full/346/17/1275.
199. CDC, Cardiac Deaths, supra note 100.
200. During the Bradford, England outbreak of 1961 (the index case imported
smallpox from Pakistan via air travel), "[p]ratically the whole of the town's
population of 250,000 was vaccinated within 5 days." Fenner, supra note 12, at
1078-79.
201. CDC, Recommendations, supra note 10.
202. The 1961 Bradford outbreak highlights several key points:
1. "The response to the provision of vaccination clinics demonstrated the
existence of considerable public fear and apprehension about smallpox."
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being vaccinated and developing smallpox is much greater than the
risk of vaccine complications for all but the most severely
immunocompromised individuals. The risk of exposure to vaccinia
becomes much less significant when most people will already be
exposed to vaccinia through vaccinations. Even in hospitals, most
patients would be candidates for vaccination in an outbreak, and for
those who are not, the low risk of vaccinia exposure from vaccinated
health care workers would be much less than the risk of spread of
the disease by unvaccinated workers. Stripped of the paperwork
requirements, and with an adequate supply of vaccine and the
bifurcated needles used to administer it, smallpox vaccinations take
little time. A handful of nurses could train others very quickly, then
fan out and vaccinate every health care worker in a facility. The
same could be done by EMTs in ambulance services and in clinics.
With the supplies in place ahead of time, some basic training, and a
shift from worrying about vaccine injuries to worrying about
smallpox, it should be possible to vaccinate health care workers very
quickly.
The most important question in smallpox vaccination policy is how
to handle the public demand for vaccinations. Under the federal
Fenner, supra note 12, at 1079.
2. All the indigenous infections were contracted in hospital, and 4
hospitals were involved, with the transmission in 3 of them ... [which
also] illustrates the unpreparedness of hospitals in the United Kingdom to
cope with an outbreak of smallpox at that time [1961], given the large
proportion of unvaccinated professional and domestic staff, the difficulty
of recognizing haemorrhagic-type smallpox and the risks thereby incurred,
and the problems encountered in effectively containing the outbreak once
it had been recognized.
Id.
How difficult is recognizing a smallpox death in a country with no recent
familiarity with the disease? One of the 14 cases resulting from the air
travel index case, and also one of the six fatalities, was "the 37-year-old
pathologist who had performed the post-mortem on the index case ....
Id. at 1079, 1080.
3. The societal burden of even a relatively limited outbreak can be enormous:
The outbreak was already rather large by the time it was recognized as being
caused by smallpox, and there had been numerous opportunities for trans-
mission, both within hospitals and in the general community. The task of
identifying, tracing, and vaccinating more than 1400 contacts and keeping them
under surveillance was expensive, difficult and time-consuming. Although mass
vaccination was never contemplated, vaccination clinics were opened because so
many people had been already exposed by the time the outbreak was recognized.
Id. at 1079.
4. Finally, consider the difficulty of the target nation even discovering it has
been attacked during the 10-12 day incubation period as well as the formidable
response and recovery tasks of coping with, say, a dozen widely dispersed index
cases traveling throughout a highly mobile and largely unrestricted society. Id.
at 1079.
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government's current ring immunization plan, cases will be
investigated, as will all the contacts to the cases, and contacts will be
vaccinated and isolated for two weeks to make sure that they do not
develop smallpox. It is likely that the media will announce the
smallpox cases to world before local emergency preparedness
personnel are all notified. The first question they will likely ask will be,
"where and how does everyone get vaccinated?"
Under a ring immunization plan, the answer is that the general public
should not worry about getting vaccinated. Only persons in contact
with a smallpox case or working in health care or emergency services
should be vaccinated. Unfortunately, the vaccination of heath care
workers cannot be carried out in isolation from the rest of the
population. Even with a cadre of pre-vaccinated health care workers,
the rest of the health care work force would need to be vaccinated as
soon as smallpox cases are identified in the community. Once the
vaccination of health care workers starts, they will want their families,
and then their friends, vaccinated. Once it hits the news that there are
cases of smallpox and that people are being vaccinated, it is the authors'
prediction that most of the population will want to be vaccinated. The
federal government's plan, on the other hand, is based on the
assumption that the population will wait quietly while the experts
manage the epidemic.
Waiting quietly during an epidemic of one of history's great killers
does not seem likely. It is more likely that people will demand
vaccinations, perhaps storming health care institutions where
vaccinations are being given. People will also want to flee, which is a
rational response to smallpox. Not being able to obtain vaccinations
may exacerbate the pressure to flee, further complicating efforts to keep
the disease from being carried to new locations. It is likely that
politicians will demand that the general public have access to smallpox
vaccinations-the only question is how much public panic will there be
before the order is given. Once vaccinations are available, it is critical
that everyone who wants one be able to obtain it very quickly. A
requirement that people wait for several days at a vaccination clinic, as
contemplated in the federal mass vaccination plan, seems an invitation
to public disorder.
Rather than a plan based on a relatively small number of vaccination
clinics, with paperwork and consent requirements, everyone who can be
trained to give smallpox vaccinations should be sent into the community
to give them. The vaccinations should be given where people are, such
as schools, churches, shopping centers, and sports stadiums. If the area
is blanketed with people with vaccine, creating a public perception that
everyone who wants it can obtain it, the public order problem will be
lessened considerably. While many people will still want to flee, this
approach may reduce the pressure to leave.
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There are two benefits of rapidly vaccinating as many people as
possible. First, it would be more likely that there will be enough herd
immunity to stop the outbreak, even though not all second generation
cases will have been eliminated. While there may still be many
deaths, public order is more likely to be preserved. Second, and
much more controversially, it means that more people would be
vaccinated before reports of real and alleged vaccine-related injuries
are publicized.2"3 This is critical if the federal government is to keep
its promise that no one will be vaccinated against her/his will.2°4 If
too many people decline vaccination, the choice may be between
forced vaccinations and failure to stop the epidemic.
XXI. SUMMARY
It is a great irony that one of the greatest achievements of public
health, the eradication of smallpox, has left the world susceptible to
a global pandemic which could dwarf any plague in history. Was it
hubris to assume that we could really eradicate something both so
ancient and so attractive to the worst instincts of humankind? It was
certainly right to eliminate the disease. The hubris was believing that
we had done it so well that we need not be armed against it any more.
This is a lesson we should take to heart as we near the eradication of
measles and other potentially epidemic diseases. We should not be
so quick to end our vaccination programs against diseases we no
longer fear. Is there any doubt that, had we continued to vaccinate
for smallpox, we would have developed a much safer vaccine?
If our national policy is that we should be prepared for the use of
smallpox as an agent of bioterrorism, and that that our preparations
should include immunization of specific groups of people with
vaccinia virus to make them immune to smallpox, then we must
address the issues that lead to the failure of the 2002-2003 civilian
smallpox vaccination campaign. We should also reconsider present
policy in the light of the uncertainty of an outbreak, the uncertain
infectiousness of smallpox, and the risks of underestimating both the
fear that an outbreak will engender and the consequences of failing
to control an outbreak. Our current strategy does not address the
issues in ways that will allow us to move quickly enough if we have
guessed wrong in our estimation of the enemy.
203. Ironically, we may be worse off after the failed smallpox vaccination
campaign because it so frightened health care workers and the general public that
it will complicate mass vaccinations if they become necessary.
204. Senator Bill Frist, When Every Moment Counts: What You Need to Know
About Bioterrorism From the Senate's Only Doctor 86 (2002).
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